{"meta":{"query_hash":"5a8ce8db8e3a","filters":{"venue":"Therapeutic Advances in Gastroenterology"},"cohort_total":83,"direct_labels_cover":0,"predictions_cover":83,"exported":83,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5a8ce8db8e3a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Gastroenterology"},"results":[{"id":"W1584350139","doi":"10.1177/1756283x08098966","title":"Review: Current status of therapy in autoimmune liver disease","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto Western Hospital","funders":"","keywords":"Medicine; Primary sclerosing cholangitis; Autoimmune hepatitis; Azathioprine; Ursodeoxycholic acid; Liver transplantation; Primary biliary cirrhosis; Cirrhosis; Disease; Liver disease; Autoimmune disease; Gastroenterology; Internal medicine; Immunology; Transplantation","score_opus":0.02395828777097453,"score_gpt":0.33582267376770797,"score_spread":0.31186438599673344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1584350139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000444784,0.9970632,0.000064563115,0.0010984322,0.0012351071,0.0000041993976,0.000011555477,0.000006740623,0.0004717306],"genre_scores_gemma":[0.000414468,0.995793,0.00017331708,0.0010575255,0.0021683578,0.00001155721,0.000030561896,0.00000225056,0.00034894265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884063,0.00037906592,0.00025818637,0.000116438874,0.00032515873,0.000080615406],"domain_scores_gemma":[0.99556196,0.0026777133,0.00047758443,0.00009956918,0.00083558174,0.00034759176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023389005,0.0015031414,0.0037380473,0.0029856039,0.0006997692,0.0028702316,0.002239326,0.004162928,0.009739911],"category_scores_gemma":[0.0047819936,0.0004088881,0.0009836114,0.0042420384,0.0012157225,0.004322426,0.0011946077,0.004276706,0.006576902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033926344,0.00013030523,0.00022633151,0.020298775,0.00014274304,0.0004391251,0.000055211913,0.00024194634,0.0006007403,0.0015317147,0.13359854,0.8423954],"study_design_scores_gemma":[0.00010039804,0.00021492648,0.0008000218,0.0097112125,0.00028482798,0.0021546725,0.000094944786,0.000099478224,0.00020158035,0.0019196449,0.98439294,0.000025322946],"about_ca_topic_score_codex":0.0008965044,"about_ca_topic_score_gemma":0.0015395883,"teacher_disagreement_score":0.009739911,"about_ca_system_score_codex":0.001187867,"about_ca_system_score_gemma":0.002052576,"threshold_uncertainty_score":0.032583237},"labels":[],"label_agreement":null},{"id":"W1629799475","doi":"10.1177/1756283x09357579","title":"Review: Optimal use of biologics in the management of Crohn’s disease","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Crohn's disease; Intensive care medicine; Disease; Inflammatory bowel disease; Biologic Agents; Internal medicine","score_opus":0.012698105401511006,"score_gpt":0.2817255603034334,"score_spread":0.26902745490192237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1629799475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000112956215,0.9943269,0.00014263665,0.0016537039,0.0027048173,0.000009975974,0.000021907337,0.000008334586,0.0010188188],"genre_scores_gemma":[0.0008010534,0.99368864,0.00033940125,0.0014176997,0.0031020741,0.000011924084,0.00003221066,0.0000029206403,0.0006040363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991504,0.00023502132,0.00021270814,0.000065782704,0.00029415905,0.00004185313],"domain_scores_gemma":[0.99845254,0.0006918865,0.0002600522,0.00003070349,0.00045726582,0.00010750986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011726086,0.0010669312,0.0023548936,0.0021570616,0.0003981918,0.0013210098,0.0013926678,0.0022409973,0.003539707],"category_scores_gemma":[0.0033634733,0.0002632466,0.00058291835,0.0025208977,0.00062213326,0.0021796715,0.00049029995,0.0019773045,0.003339123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002628013,0.00008437328,0.00022424693,0.02455549,0.00019040487,0.0007840532,0.00005214188,0.00033549438,0.0010566589,0.0012296317,0.22735265,0.74387205],"study_design_scores_gemma":[0.00007562958,0.00012978619,0.0011472723,0.008296587,0.00020904672,0.0043296465,0.00007327153,0.000078855,0.0003565475,0.0011293476,0.98414826,0.00002563707],"about_ca_topic_score_codex":0.0007016356,"about_ca_topic_score_gemma":0.0015449764,"teacher_disagreement_score":0.003539707,"about_ca_system_score_codex":0.0007473383,"about_ca_system_score_gemma":0.0010378916,"threshold_uncertainty_score":0.011841536},"labels":[],"label_agreement":null},{"id":"W1996479060","doi":"10.1177/1756283x09337645","title":"Review: Effect of probiotics on gastrointestinal function: evidence from animal models","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Gastrointestinal function; Function (biology); Internal medicine; Biology; Evolutionary biology","score_opus":0.023755533960543952,"score_gpt":0.31082831028862895,"score_spread":0.287072776328085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996479060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007130477,0.99757105,0.000086693595,0.0005741614,0.00038883995,0.00000802078,0.00007813419,0.000007788462,0.00057222747],"genre_scores_gemma":[0.0031513898,0.9954674,0.0002062347,0.0004886699,0.0003751548,0.000012411369,0.00007460029,0.000003688679,0.00022036047],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99949074,0.00015093079,0.00011578955,0.00006695457,0.00014915293,0.000026328837],"domain_scores_gemma":[0.997789,0.0013698045,0.00034600703,0.00005163946,0.0003534978,0.00009000491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012808728,0.001008368,0.0024999352,0.001331885,0.00020816295,0.000826295,0.0008784496,0.0017104344,0.0038374967],"category_scores_gemma":[0.0029930465,0.00019514759,0.0005766656,0.0019557702,0.00054024736,0.0009314283,0.00050297106,0.0010219218,0.0019357816],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003534595,0.0003187951,0.0009583113,0.103985794,0.0009923929,0.0010696782,0.000100809244,0.00016225323,0.013795937,0.00084742595,0.058286138,0.81594783],"study_design_scores_gemma":[0.0008698144,0.004277512,0.018139593,0.030639334,0.0049244002,0.009428852,0.0002857014,0.00015515918,0.013081941,0.0020324585,0.9160595,0.000105836116],"about_ca_topic_score_codex":0.00056662696,"about_ca_topic_score_gemma":0.0006851994,"teacher_disagreement_score":0.0038374967,"about_ca_system_score_codex":0.0002466149,"about_ca_system_score_gemma":0.00068258937,"threshold_uncertainty_score":0.012837708},"labels":[],"label_agreement":null},{"id":"W1998545651","doi":"10.1177/1756283x12473676","title":"Colonoscopy and colorectal cancer mortality: both sides of the story","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Medicine; Colorectal cancer; Colonoscopy; Cancer; General surgery; Internal medicine; Oncology","score_opus":0.015132518994743806,"score_gpt":0.2997473541011446,"score_spread":0.2846148351064008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998545651","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018802579,0.35045892,0.00049055374,0.6352593,0.007226755,0.000004790806,0.00021116056,0.000020072146,0.0044482257],"genre_scores_gemma":[0.04094771,0.65756583,0.0009285955,0.20620638,0.09079796,0.000029391924,0.00024163825,0.000059364254,0.0032231556],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940882,0.0025724417,0.00044148392,0.0008634509,0.001584525,0.00045004158],"domain_scores_gemma":[0.9592837,0.029189562,0.0027355098,0.0011900708,0.0049901325,0.0026110196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009732919,0.00080632983,0.002003727,0.0026919304,0.0017546912,0.005481034,0.001688924,0.010466088,0.012452157],"category_scores_gemma":[0.040570907,0.00051891396,0.0021272253,0.002806266,0.006979578,0.01586703,0.0038845115,0.021686915,0.0021975697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011476357,0.00024437663,0.014911831,0.0032717648,0.00057430024,0.00056834467,0.0012372287,0.00066242623,0.0003361381,0.19771332,0.4369084,0.3424243],"study_design_scores_gemma":[0.00022313333,0.00053292146,0.026638877,0.011192533,0.00052842335,0.002210702,0.0031267095,0.0009829086,0.00027041667,0.2752627,0.6787606,0.00027014563],"about_ca_topic_score_codex":0.008870508,"about_ca_topic_score_gemma":0.0062705083,"teacher_disagreement_score":0.012452157,"about_ca_system_score_codex":0.003205677,"about_ca_system_score_gemma":0.003286469,"threshold_uncertainty_score":0.0514732},"labels":[],"label_agreement":null},{"id":"W1999882842","doi":"10.1177/1756283x09354562","title":"Review: Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Adverse effect; Tenofovir; Drug; Cirrhosis; Clinical trial; Intensive care medicine; Hepatocellular carcinoma; Hepatitis B virus; Hepatitis B; Human immunodeficiency virus (HIV); Pharmacology; Internal medicine; Virology; Virus","score_opus":0.006064862638581816,"score_gpt":0.2661952676658336,"score_spread":0.2601304050272518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999882842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033048872,0.99785703,0.000047736994,0.00037771015,0.00050456537,0.000016611702,0.00003758454,0.000004018725,0.0008242005],"genre_scores_gemma":[0.003377628,0.9945004,0.00018519492,0.00057599787,0.0007632438,0.000022035236,0.000054190783,0.0000022473025,0.0005190337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923635,0.0002763585,0.0002183617,0.00004774676,0.00019758723,0.000023586908],"domain_scores_gemma":[0.9971826,0.0018121756,0.00043060558,0.000031717525,0.00046836922,0.00007459091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012662471,0.0007325376,0.0023664874,0.0014900252,0.00023386498,0.00083117053,0.00083559647,0.0011475426,0.0038106672],"category_scores_gemma":[0.004444295,0.00017532447,0.00067629485,0.0016788153,0.00034208872,0.0008241758,0.0002331981,0.00069325813,0.0013262912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007148077,0.000071020346,0.0004864731,0.093325086,0.00052489864,0.00041343094,0.00007611679,0.00012925066,0.0011800121,0.00033958495,0.052485663,0.8502537],"study_design_scores_gemma":[0.0005149986,0.0017744213,0.010439067,0.06575877,0.0030463843,0.00816363,0.00021461686,0.00015878733,0.0015024309,0.00065477984,0.90773,0.000042161537],"about_ca_topic_score_codex":0.0011292972,"about_ca_topic_score_gemma":0.0017305433,"teacher_disagreement_score":0.0038106672,"about_ca_system_score_codex":0.00051770406,"about_ca_system_score_gemma":0.0011470607,"threshold_uncertainty_score":0.012748003},"labels":[],"label_agreement":null},{"id":"W2002861309","doi":"10.1177/1756283x11405250","title":"Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease","year":2011,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Mesalazine; Inflammatory bowel disease; Ulcerative colitis; Dosing; Clinical trial; Disease; Intensive care medicine; Internal medicine; Crohn's disease; Aminosalicylic acid; Randomized controlled trial; Gastroenterology","score_opus":0.031191929865220014,"score_gpt":0.29661892575409154,"score_spread":0.26542699588887153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002861309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2317669,0.6350857,0.034367092,0.043588374,0.0016662179,0.0006985745,0.00028261458,0.0004158323,0.052128706],"genre_scores_gemma":[0.8019263,0.14709009,0.038511164,0.007483982,0.0016989791,0.00040233915,0.00020918225,0.000077752185,0.0026002275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952655,0.0026776053,0.00068630354,0.00022381429,0.0009723357,0.00017446939],"domain_scores_gemma":[0.9972012,0.00091655174,0.0008603779,0.00009084728,0.0006228395,0.00030825377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043277773,0.0002870051,0.0007414031,0.0005405878,0.0002689732,0.0012973294,0.00044493162,0.00057088025,0.0017418674],"category_scores_gemma":[0.011529678,0.00011523164,0.00044053092,0.0005291288,0.00030221872,0.0008257016,0.0005946916,0.0009052839,0.0007076467],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013893383,0.0006653206,0.018940665,0.0022688103,0.00024257216,0.0003573495,0.00051574985,0.001253892,0.008560726,0.0019242073,0.010787939,0.9530934],"study_design_scores_gemma":[0.0018851127,0.017968033,0.24194874,0.0127535695,0.0028864446,0.0050639915,0.003411331,0.008443222,0.028216265,0.008675886,0.66852826,0.00021914508],"about_ca_topic_score_codex":0.0010917194,"about_ca_topic_score_gemma":0.0019908177,"teacher_disagreement_score":0.0043277773,"about_ca_system_score_codex":0.00076166255,"about_ca_system_score_gemma":0.0014939031,"threshold_uncertainty_score":0.022887707},"labels":[],"label_agreement":null},{"id":"W2007340026","doi":"10.1177/1756283x08092548","title":"Review: Efficacy and safety of adalimumab in Crohn's disease","year":2008,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Concomitant; Crohn's disease; Placebo; Internal medicine; Monoclonal antibody; Gastroenterology; Immunogenicity; Population; Tumor necrosis factor alpha; Antibody; Surgery; Disease; Immunology; Pathology","score_opus":0.008379344914020771,"score_gpt":0.26455949776942594,"score_spread":0.2561801528554052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007340026","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008199684,0.99878854,0.00002417266,0.0002583983,0.00040569028,0.000013158112,0.000057285182,0.000004617826,0.0003660869],"genre_scores_gemma":[0.0010931597,0.99746144,0.00006690434,0.00057356566,0.0004694184,0.000019542747,0.00008234994,0.0000026345572,0.0002310339],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9990922,0.00021944827,0.00030820753,0.000090199,0.0002577303,0.000032157368],"domain_scores_gemma":[0.99638915,0.0022169212,0.00072755304,0.000046435922,0.0005058295,0.000114097624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014353421,0.00085906714,0.004255761,0.0027809753,0.00034509556,0.0018754124,0.0015968098,0.0017506076,0.007994458],"category_scores_gemma":[0.004791935,0.0003878102,0.0013372876,0.0038985186,0.0005161485,0.0012565581,0.0006967384,0.0014220177,0.0015879543],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004176798,0.00003709943,0.00020842288,0.41965246,0.0009917223,0.00014940239,0.00009156506,0.00013081061,0.0003685289,0.0007376379,0.07667804,0.5005366],"study_design_scores_gemma":[0.00035506557,0.00041629473,0.0038497136,0.29128528,0.006103898,0.0016550558,0.00018691806,0.00014190283,0.0003223814,0.0010614888,0.69456816,0.00005394269],"about_ca_topic_score_codex":0.0014738461,"about_ca_topic_score_gemma":0.0023561185,"teacher_disagreement_score":0.007994458,"about_ca_system_score_codex":0.000994666,"about_ca_system_score_gemma":0.0019016359,"threshold_uncertainty_score":0.026744068},"labels":[],"label_agreement":null},{"id":"W2008468214","doi":"10.1177/1756283x10366368","title":"Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Context (archaeology); Tumor necrosis factor alpha; Perspective (graphical); Pandemic; Intensive care medicine; Tumor necrosis factor α; Immunology; Vaccination; Coronavirus disease 2019 (COVID-19); Pathology; Disease; Infectious disease (medical specialty)","score_opus":0.06392682970734659,"score_gpt":0.4092232274303356,"score_spread":0.34529639772298903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008468214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008017114,0.97847044,0.00008255111,0.0039047133,0.016761595,0.000009222842,0.000017792368,0.0000075032754,0.00066601555],"genre_scores_gemma":[0.00056230737,0.9735851,0.0001303054,0.0051383353,0.019418232,0.000011817956,0.000026545478,0.0000027061335,0.0011245933],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99929345,0.0001904819,0.00014429344,0.00008230835,0.0002424512,0.00004703808],"domain_scores_gemma":[0.9965933,0.0019491627,0.00035861222,0.000052445394,0.0008144609,0.0002318532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014046076,0.001513651,0.0028160508,0.0020432295,0.0006292387,0.0020147956,0.0015429418,0.004019835,0.0037366892],"category_scores_gemma":[0.003513376,0.00036511666,0.00076725363,0.003258591,0.0008740983,0.0040479177,0.0006826603,0.0031294313,0.003261665],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042178188,0.000093430725,0.00028310184,0.026687406,0.00027959686,0.0011455019,0.00007655922,0.0003203186,0.0012366802,0.0014311053,0.5940633,0.37396115],"study_design_scores_gemma":[0.00006981459,0.00020152934,0.0011495452,0.008333836,0.0002645675,0.0034857248,0.00015660703,0.00009154324,0.0002550022,0.0017150581,0.98424613,0.000030632218],"about_ca_topic_score_codex":0.0012640089,"about_ca_topic_score_gemma":0.0031256434,"teacher_disagreement_score":0.004019835,"about_ca_system_score_codex":0.000946957,"about_ca_system_score_gemma":0.0015272282,"threshold_uncertainty_score":0.012500405},"labels":[],"label_agreement":null},{"id":"W2075010011","doi":"10.1177/1756283x10392443","title":"Eosinophilic colitis: epidemiology, clinical features, and current management","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"European Genomic Institute for Diabetes","keywords":"Medicine; Eosinophilic gastroenteritis; Eosinophilic esophagitis; Eosinophilia; Colitis; Eosinophilic; Immunology; Microscopic colitis; Bloody diarrhea; Abdominal pain; Diarrhea; Gastroenterology; Internal medicine; Inflammatory bowel disease; Pathology; Disease","score_opus":0.03085667099242003,"score_gpt":0.39091677512573414,"score_spread":0.36006010413331413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075010011","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004261592,0.99250317,0.00034171133,0.0009799587,0.000113992835,0.000009528632,0.000068141104,0.000024464844,0.0016974075],"genre_scores_gemma":[0.027101954,0.96978956,0.000724122,0.00060925656,0.0010070034,0.000019453862,0.00028759762,0.0000067824053,0.00045426138],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971825,0.00006188511,0.00006916752,0.000056491666,0.000058244674,0.000035996058],"domain_scores_gemma":[0.99958986,0.00013720522,0.00012921523,0.000007986691,0.00007178274,0.000064014865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041259927,0.0004615513,0.0008174786,0.0016173626,0.00028595925,0.00095076073,0.0004310754,0.0006359406,0.0014048184],"category_scores_gemma":[0.0009719506,0.00016015317,0.00034022753,0.0016009482,0.00033866015,0.0009254709,0.00041068607,0.0010554916,0.00050076935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029507442,0.00015603281,0.02145215,0.008414975,0.00017594158,0.0030259334,0.00026589222,0.00038730746,0.0013329035,0.0017402585,0.023271013,0.93948257],"study_design_scores_gemma":[0.00014130694,0.00079887017,0.15568556,0.029337157,0.0011771666,0.15272231,0.0020083871,0.0012172506,0.001251456,0.007861017,0.6476196,0.00017998027],"about_ca_topic_score_codex":0.00088588125,"about_ca_topic_score_gemma":0.0012237506,"teacher_disagreement_score":0.0016173626,"about_ca_system_score_codex":0.0004424991,"about_ca_system_score_gemma":0.00061038166,"threshold_uncertainty_score":0.004699588},"labels":[],"label_agreement":null},{"id":"W2108127670","doi":"10.1177/1756283x10382816","title":"Exploring the role of monitoring anti-TNFα drug and antibody levels in the management of inflammatory bowel disease","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Adverse effect; Tumor necrosis factor alpha; Disease; Drug; Immunology; Immunogenicity; Infliximab; Internal medicine; Antibody; Intensive care medicine; Gastroenterology; Pharmacology","score_opus":0.012635517506755423,"score_gpt":0.26872174925498943,"score_spread":0.25608623174823403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108127670","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031757228,0.9525403,0.00400981,0.006193292,0.00046592727,0.00003211956,0.00002220916,0.000043444004,0.0049357316],"genre_scores_gemma":[0.17617993,0.80799776,0.010159024,0.0029324093,0.0012892798,0.00004866285,0.000035584882,0.000012727906,0.0013446023],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993668,0.00034446188,0.000058531292,0.000036106954,0.00016661314,0.000027425636],"domain_scores_gemma":[0.9989209,0.0005986472,0.00019504348,0.000025196094,0.0001964932,0.00006376445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001993698,0.00027587212,0.00085395126,0.0004746839,0.00012947037,0.0008062407,0.00036790664,0.0007865679,0.0006691371],"category_scores_gemma":[0.002149611,0.000121469944,0.00031467786,0.00049679494,0.00035713214,0.00080456375,0.0002002077,0.0007319518,0.0002866922],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013531378,0.0003302734,0.010692157,0.0032427015,0.00021148012,0.0017594368,0.00017793829,0.0010087758,0.022392822,0.0026381384,0.0034398527,0.9527532],"study_design_scores_gemma":[0.0011232361,0.016335774,0.11542042,0.0072465437,0.0022251543,0.027847964,0.0015524173,0.005452674,0.053468373,0.01952328,0.7496102,0.00019398415],"about_ca_topic_score_codex":0.00038750307,"about_ca_topic_score_gemma":0.0005610987,"teacher_disagreement_score":0.001993698,"about_ca_system_score_codex":0.00037587658,"about_ca_system_score_gemma":0.00082188495,"threshold_uncertainty_score":0.010543823},"labels":[],"label_agreement":null},{"id":"W2126805615","doi":"10.1177/1756283x13502637","title":"Aflibercept in the treatment of patients with metastatic colorectal cancer: latest findings and interpretations","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Aflibercept; Medicine; Bevacizumab; Regorafenib; Colorectal cancer; Placental growth factor; Vascular endothelial growth factor; Angiogenesis; Oncology; Chemotherapy; Internal medicine; Cancer; Cancer research; VEGF receptors","score_opus":0.006768711707801027,"score_gpt":0.26196187607555443,"score_spread":0.2551931643677534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126805615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024429548,0.9928114,0.00021406288,0.0028792524,0.00025417635,0.0000071639984,0.000029380068,0.000010156723,0.0013513839],"genre_scores_gemma":[0.021300524,0.97361135,0.0008321589,0.0019390141,0.0017072447,0.00001719624,0.00006925975,0.000007316764,0.00051586214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995555,0.00011890418,0.00008994226,0.000079730344,0.00011891394,0.000036954392],"domain_scores_gemma":[0.9982495,0.00082623906,0.00030890323,0.00004282212,0.0004557261,0.0001166978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024243318,0.0004296555,0.0011686176,0.0008131795,0.00014778378,0.0011723572,0.00056344486,0.00078488846,0.00093576644],"category_scores_gemma":[0.002245065,0.00014965935,0.00049111526,0.0014682603,0.0005073567,0.0011735193,0.00029254274,0.0014527687,0.000381027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007757703,0.00014246361,0.0027880403,0.004911012,0.00011905847,0.0004264355,0.000108355685,0.00041508867,0.0034127694,0.0016058966,0.010262395,0.9750327],"study_design_scores_gemma":[0.0009124853,0.0065329126,0.04959079,0.0123491045,0.0018883329,0.0081436075,0.0007003287,0.0020840955,0.007967074,0.008074001,0.901598,0.00015942531],"about_ca_topic_score_codex":0.00091404037,"about_ca_topic_score_gemma":0.0014987584,"teacher_disagreement_score":0.0024243318,"about_ca_system_score_codex":0.00070299365,"about_ca_system_score_gemma":0.0009597455,"threshold_uncertainty_score":0.012821257},"labels":[],"label_agreement":null},{"id":"W2129520988","doi":"10.1177/1756283x08103341","title":"Effective treatment of chronic radiation proctitis using radiofrequency ablation","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Air Force Office of Scientific Research; National Science Council","keywords":"Medicine; Argon plasma coagulation; Radiation proctitis; Radiofrequency ablation; Ablation; Ablative case; Esophagus; Proctitis; Submucosa; Endoscopy; Surgery; Radiology; Hemostasis; Coagulative necrosis; Radiation therapy; Internal medicine","score_opus":0.00808402207589402,"score_gpt":0.2718305615056287,"score_spread":0.26374653942973464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129520988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92368644,0.057624564,0.012019788,0.00050862134,0.000085263746,0.00017982363,0.000079447724,0.00023288866,0.0055832765],"genre_scores_gemma":[0.98677075,0.008372848,0.003523365,0.0003088987,0.00015417452,0.00008147633,0.00009893618,0.000031017793,0.00065860036],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998535,0.000041748666,0.000015429032,0.000022078273,0.000027805094,0.000039488375],"domain_scores_gemma":[0.9998166,0.000050599272,0.000048869566,0.00002573605,0.000010949573,0.000047268986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037670648,0.00035020662,0.0006424209,0.00038430508,0.00046540133,0.00031274132,0.00020686856,0.0003516397,0.0011713565],"category_scores_gemma":[0.00047786685,0.00013448104,0.00043880625,0.00023323302,0.0004801757,0.00024106012,0.00039796738,0.0004673376,0.00029140507],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033459344,0.0015761402,0.09076016,0.0024789607,0.00046034734,0.018442567,0.0010914534,0.00071625796,0.31772196,0.00076940603,0.0022560917,0.56038064],"study_design_scores_gemma":[0.0025008668,0.037303936,0.47008255,0.00070598465,0.0010241888,0.27587065,0.0007801492,0.002295652,0.15456611,0.000971475,0.053770326,0.00012805345],"about_ca_topic_score_codex":0.00020323737,"about_ca_topic_score_gemma":0.00040766518,"teacher_disagreement_score":0.0011713565,"about_ca_system_score_codex":0.00013064242,"about_ca_system_score_gemma":0.00019045419,"threshold_uncertainty_score":0.0039185286},"labels":[],"label_agreement":null},{"id":"W2136508080","doi":"10.1177/1756283x10377820","title":"Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Vitamin D and neurology; Colorectal cancer; Immune system; Disease; Cancer; Gastrointestinal cancer; vitamin D deficiency; Prostate cancer; Vitamin; Gastroenterology; Internal medicine; Immunology","score_opus":0.007395304322795506,"score_gpt":0.29648305935644353,"score_spread":0.28908775503364803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136508080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091702456,0.99432796,0.00008145031,0.0017812556,0.00042822477,0.0000049419664,0.000016152597,0.000004942249,0.0024380393],"genre_scores_gemma":[0.012486472,0.9822468,0.00034772145,0.0009046089,0.00159885,0.000008230173,0.000045922,0.0000016729512,0.0023597202],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996582,0.00012125603,0.00004748477,0.00003594207,0.000110454894,0.000026715203],"domain_scores_gemma":[0.9995492,0.00019599394,0.00009673577,0.000010318205,0.00008793138,0.00005971324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042808274,0.00048622926,0.00095759955,0.0018941875,0.000380261,0.0009315006,0.00035085678,0.0011216123,0.0053580357],"category_scores_gemma":[0.00076839875,0.00013757039,0.00032777674,0.0030374958,0.00058320037,0.00064551854,0.00068873964,0.000780114,0.0010188678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008530595,0.00028008313,0.015157983,0.015443584,0.0003719416,0.0018086166,0.00039147906,0.0002946189,0.003308021,0.009025705,0.052083958,0.9009809],"study_design_scores_gemma":[0.000106387335,0.0008161159,0.056464106,0.005608716,0.0003888712,0.014088355,0.0007000276,0.00016299763,0.0007592744,0.011256086,0.9095958,0.000053192474],"about_ca_topic_score_codex":0.0025004141,"about_ca_topic_score_gemma":0.0061724484,"teacher_disagreement_score":0.0053580357,"about_ca_system_score_codex":0.0005963336,"about_ca_system_score_gemma":0.00091722474,"threshold_uncertainty_score":0.017924428},"labels":[],"label_agreement":null},{"id":"W2149394302","doi":"10.1177/1756283x11398930","title":"Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease","year":2011,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Disease; Natural history; Crohn's disease; Ulcerative colitis; Gastroenterology; Intensive care medicine; Internal medicine","score_opus":0.006238623844901913,"score_gpt":0.23604573324984834,"score_spread":0.22980710940494642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149394302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015618597,0.9640169,0.0011292628,0.012633992,0.0010390074,0.000009429338,0.000040682546,0.000028340066,0.00548382],"genre_scores_gemma":[0.1900761,0.7927698,0.0034703237,0.0067066113,0.0028443628,0.000025811642,0.00006646118,0.00003101858,0.004009569],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994554,0.00025337742,0.0000602253,0.00005545739,0.00012263509,0.000052988],"domain_scores_gemma":[0.9992446,0.0002966426,0.00016313391,0.000024718507,0.00016244847,0.000108417924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011552057,0.00028381977,0.0006063866,0.00085020514,0.000381985,0.0016608165,0.00035040252,0.0012011171,0.0008838018],"category_scores_gemma":[0.002506467,0.00010862457,0.00025815406,0.000837862,0.0012863324,0.001976122,0.00063661457,0.001827114,0.00034654274],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009973478,0.00016661227,0.02059904,0.0055547883,0.00020461943,0.0024441464,0.0029107814,0.00045136712,0.018097335,0.03174711,0.02606604,0.8907608],"study_design_scores_gemma":[0.000121376506,0.002832807,0.15206142,0.007450715,0.0004741494,0.034441352,0.0065560606,0.0010729393,0.006959207,0.07934353,0.70847476,0.00021173911],"about_ca_topic_score_codex":0.00060751487,"about_ca_topic_score_gemma":0.00077797286,"teacher_disagreement_score":0.0016608165,"about_ca_system_score_codex":0.0008819582,"about_ca_system_score_gemma":0.0005597256,"threshold_uncertainty_score":0.0063990355},"labels":[],"label_agreement":null},{"id":"W2291264396","doi":"10.1177/1756283x15607414","title":"Fecal microbiota transplantation: in perspective","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":485,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; University of Guelph; Queen's University","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Fecal bacteriotherapy; Microbiome; Medicine; Clostridium difficile; Transplantation; Gut flora; Irritable bowel syndrome; Gastrointestinal tract; Inflammatory bowel disease; Feces; Dysbiosis; Immunology; Disease; Bioinformatics; Gastroenterology; Internal medicine; Biology; Microbiology; Antibiotics","score_opus":0.057922753991474306,"score_gpt":0.41139966234684777,"score_spread":0.3534769083553735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291264396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000989672,0.9970386,0.00008478508,0.0011872944,0.00080546015,0.000002250195,0.000011700402,0.0000051063284,0.00076591026],"genre_scores_gemma":[0.0007612089,0.99658775,0.00011690422,0.0008767361,0.0010570269,0.0000037654065,0.00002211354,0.0000019213649,0.00057248835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978167,0.000046032223,0.000039885846,0.00004340325,0.000067830966,0.000021114758],"domain_scores_gemma":[0.9993668,0.00031323347,0.00007575177,0.000019404079,0.00015613064,0.000068634974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000786367,0.0007011179,0.0011922284,0.0017450294,0.00026405702,0.0014851445,0.000673635,0.0017436194,0.0058369525],"category_scores_gemma":[0.0012731798,0.0001895059,0.0005929885,0.0013222559,0.0005329464,0.0024703247,0.00079715136,0.0025279592,0.0023527504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014483283,0.00006740017,0.00031394744,0.01689638,0.00009671742,0.0005630585,0.000077099045,0.00018895924,0.0010781096,0.0061663557,0.04777211,0.926635],"study_design_scores_gemma":[0.000020548498,0.000094580624,0.00070456817,0.006609552,0.00010497924,0.003254785,0.00010696905,0.00006104388,0.00030277605,0.0032559426,0.98546785,0.000016247839],"about_ca_topic_score_codex":0.00055831415,"about_ca_topic_score_gemma":0.0012382558,"teacher_disagreement_score":0.0058369525,"about_ca_system_score_codex":0.00043872985,"about_ca_system_score_gemma":0.00090859574,"threshold_uncertainty_score":0.0195266},"labels":[],"label_agreement":null},{"id":"W2312759778","doi":"10.1177/1756283x16635081","title":"The role of vedolizumab in patients with moderate-to-severe Crohn’s disease and ulcerative colitis","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Crohn's disease; Internal medicine; Inflammatory bowel disease; Gastroenterology; Disease; Clinical trial","score_opus":0.005654130052781828,"score_gpt":0.25759159569248957,"score_spread":0.25193746563970776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312759778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011092475,0.9996153,0.000011282365,0.0000684206,0.000026670044,0.0000018247126,0.0000056580548,8.869064e-7,0.0001589592],"genre_scores_gemma":[0.0018287657,0.9977647,0.00006244494,0.00013546943,0.00006561284,0.0000059414997,0.000021748116,4.991847e-7,0.00011479402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997384,0.000070776,0.000070798815,0.000033089702,0.00006849268,0.00001837961],"domain_scores_gemma":[0.99964714,0.00019991289,0.000081147504,0.000005456094,0.000045204473,0.00002113833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006288709,0.00050259125,0.0017498878,0.0018793877,0.00016126494,0.0005491106,0.00064778124,0.0007865334,0.0018245433],"category_scores_gemma":[0.0010773886,0.00019444217,0.0007877718,0.001618713,0.0002484477,0.00076727115,0.0003782625,0.0008067157,0.00048016608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000522094,0.00006513969,0.00055638293,0.06286254,0.00045007936,0.000317046,0.0000690439,0.00011879466,0.0008397611,0.0007870858,0.01099288,0.92241913],"study_design_scores_gemma":[0.0010033059,0.0010839372,0.015575181,0.06392795,0.004070351,0.009629221,0.00030053238,0.0002901872,0.0012212084,0.0025030184,0.9003129,0.00008217533],"about_ca_topic_score_codex":0.000865941,"about_ca_topic_score_gemma":0.0017727561,"teacher_disagreement_score":0.0018793877,"about_ca_system_score_codex":0.00038206784,"about_ca_system_score_gemma":0.00074284547,"threshold_uncertainty_score":0.006103754},"labels":[],"label_agreement":null},{"id":"W2323758366","doi":"10.1177/1756283x16638833","title":"Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Inflammatory bowel disease; Tumor necrosis factor alpha; Disease; Vedolizumab; Immunology; Intensive care medicine; Monoclonal antibody; Tumor necrosis factor α; Ulcerative colitis; Internal medicine; Infliximab; Crohn's disease; Oncology; Antibody","score_opus":0.017210947681713502,"score_gpt":0.3092586221245753,"score_spread":0.2920476744428618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323758366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002783927,0.9989485,0.00013912686,0.00017604434,0.00008197776,0.0000031256889,0.00002011762,0.0000038026228,0.00034904116],"genre_scores_gemma":[0.0021799207,0.9971662,0.0002480918,0.000095103795,0.00012022739,0.00000508944,0.00003676389,0.0000011096578,0.00014751038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966335,0.000080653415,0.000075147,0.00005215676,0.000107072934,0.000021625066],"domain_scores_gemma":[0.99930096,0.00038802493,0.0001298234,0.00001328958,0.00014025214,0.000027658216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008666847,0.0006662723,0.0015425391,0.0019909486,0.00012575736,0.0009239246,0.00061945774,0.00082684244,0.0011289223],"category_scores_gemma":[0.0016006526,0.00019206939,0.0005806828,0.0014875167,0.00037579794,0.0007095399,0.0004995367,0.0009874061,0.0007523025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013630987,0.00005061134,0.0018871351,0.014141385,0.00024555394,0.00024467477,0.00004240156,0.0003950911,0.000977369,0.0010542059,0.007839679,0.9729856],"study_design_scores_gemma":[0.00009178987,0.00052791904,0.021247124,0.027012438,0.0019729116,0.011015862,0.00030934473,0.0010528956,0.0026515548,0.006469687,0.92752033,0.0001281188],"about_ca_topic_score_codex":0.0006328325,"about_ca_topic_score_gemma":0.00084214506,"teacher_disagreement_score":0.0019909486,"about_ca_system_score_codex":0.000424482,"about_ca_system_score_gemma":0.0007390544,"threshold_uncertainty_score":0.004583478},"labels":[],"label_agreement":null},{"id":"W2336474906","doi":"10.1177/1756283x15618130","title":"Ustekinumab for the treatment of Crohn’s disease: can it find its niche?","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ustekinumab; Medicine; Crohn's disease; Psoriatic arthritis; Psoriasis; Disease; Vedolizumab; Infliximab; Adalimumab; Immunology; Cohort; Secukinumab; Pharmacotherapy; Internal medicine","score_opus":0.03938787289550029,"score_gpt":0.35108627012152444,"score_spread":0.31169839722602416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336474906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000065156986,0.9989868,0.00004045882,0.00029401106,0.00016173684,0.0000022490256,0.000009019777,0.0000031616203,0.00043748255],"genre_scores_gemma":[0.00042260127,0.9986426,0.000084108804,0.0002924564,0.00017599865,0.000002693808,0.000016795326,0.0000011402733,0.0003615295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980325,0.000036970567,0.00003640874,0.00002689907,0.00007950657,0.000017116818],"domain_scores_gemma":[0.99969864,0.00014534351,0.00004806973,0.000008429226,0.000069174086,0.000030454672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000568867,0.0005614078,0.001255396,0.0018110083,0.00023435983,0.0009072281,0.0007344664,0.0010181953,0.0039140503],"category_scores_gemma":[0.00085768045,0.00019536878,0.0005396972,0.0016713168,0.00038488768,0.0013623909,0.0005488139,0.0018930455,0.0022408448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088394794,0.000040947172,0.00013571297,0.012242605,0.00008691853,0.00020468493,0.0000432634,0.00013319217,0.00078517117,0.0018895442,0.027874313,0.9564752],"study_design_scores_gemma":[0.000033959124,0.000079492034,0.0005922069,0.0047389744,0.00012890936,0.001807909,0.00005215139,0.000045139335,0.0002136354,0.0014702515,0.99082315,0.000014092179],"about_ca_topic_score_codex":0.0006223302,"about_ca_topic_score_gemma":0.0017067597,"teacher_disagreement_score":0.0039140503,"about_ca_system_score_codex":0.00040495215,"about_ca_system_score_gemma":0.0006707464,"threshold_uncertainty_score":0.013093829},"labels":[],"label_agreement":null},{"id":"W2338178060","doi":"10.1177/1756283x16637819","title":"Novel perspectives on therapeutic modulation of the gut microbiota","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Canada Research Chairs; Canadian Celiac Association","keywords":"Gut flora; Immune system; Medicine; Disease; Inflammatory bowel disease; Immunology; Inflammation; Immune modulation; Mechanism (biology); Adverse effect; Bioinformatics; Biology; Pharmacology; Pathology","score_opus":0.021657831990492423,"score_gpt":0.32979951580502764,"score_spread":0.3081416838145352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338178060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014189121,0.997417,0.00022138453,0.0007981161,0.00048771786,0.0000046202445,0.000011660999,0.000008005146,0.00090958417],"genre_scores_gemma":[0.0011299341,0.99682176,0.00036831084,0.0004939571,0.0005249961,0.000010367276,0.0000249427,0.0000024532135,0.000623415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975723,0.000056628396,0.000030673298,0.000044536308,0.000075129705,0.000035921403],"domain_scores_gemma":[0.99965274,0.00018518086,0.000033643253,0.00001342677,0.00007064269,0.000044381315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008347485,0.0008736977,0.00132464,0.0016732719,0.00028700946,0.0011353764,0.0009795695,0.001819096,0.005023342],"category_scores_gemma":[0.000824734,0.00019933304,0.0006578028,0.0009959338,0.0007691778,0.0018266357,0.0008757439,0.0034147338,0.0017346118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016253463,0.00019915489,0.0001770052,0.01618235,0.00010371746,0.0005398022,0.000101952806,0.00038095203,0.005522632,0.012459908,0.03068556,0.9334845],"study_design_scores_gemma":[0.00004502241,0.00020652027,0.0005862861,0.003619416,0.00008617588,0.0019468192,0.00007592075,0.0001243469,0.0010474005,0.005935193,0.9863057,0.000021242979],"about_ca_topic_score_codex":0.0003393348,"about_ca_topic_score_gemma":0.00073734,"teacher_disagreement_score":0.005023342,"about_ca_system_score_codex":0.00054051884,"about_ca_system_score_gemma":0.00082323665,"threshold_uncertainty_score":0.016804695},"labels":[],"label_agreement":null},{"id":"W2531079766","doi":"10.1177/1756283x16671670","title":"Silicone-covered biodegradable magnesium-stent insertion in the esophagus: a comparison with plastic stents","year":2016,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Magnesium Alloys: Properties and Applications","field":"Materials Science","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China; Jiangsu Provincial Clinical Orthopedic Center","keywords":"Medicine; Stent; Esophagus; Magnesium; Surgery; Silicone; Esophageal stent; Materials science","score_opus":0.016942241397172188,"score_gpt":0.25526469313301353,"score_spread":0.23832245173584135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531079766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873,0.00064800045,0.00044256388,0.000008755155,0.000004807115,0.000009896528,0.0000067591905,0.000003490167,0.00014575903],"genre_scores_gemma":[0.99796665,0.00060509,0.0010009021,0.000024140474,0.000008978649,0.00001594085,0.000047785143,0.0000028564893,0.00032777997],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997205,0.00007064068,0.000037781745,0.000046802084,0.000072892646,0.00005131994],"domain_scores_gemma":[0.999491,0.00009389526,0.00023876275,0.000047522488,0.000061698694,0.000067134635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057161687,0.00035875407,0.00028501343,0.00031243465,0.000111903566,0.00024491837,0.00015365746,0.00043333892,0.00050912786],"category_scores_gemma":[0.0006283571,0.00022595796,0.00037546703,0.00011235039,0.00031827675,0.00046853794,0.00018943868,0.0001898334,0.00016404789],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008533348,0.000058921465,0.0033847147,0.00006568277,0.000012332179,0.00012086937,0.00004409245,0.000034659293,0.99338114,0.00001675365,0.000005755444,0.002021753],"study_design_scores_gemma":[0.000066929395,0.019689228,0.07375732,0.000028702143,0.00015449876,0.001868551,0.00024093282,0.0011856885,0.90145165,0.000043464734,0.0014992002,0.000013819804],"about_ca_topic_score_codex":0.00020558239,"about_ca_topic_score_gemma":0.0002918068,"teacher_disagreement_score":0.00057161687,"about_ca_system_score_codex":0.00014828176,"about_ca_system_score_gemma":0.00010724644,"threshold_uncertainty_score":0.003023088},"labels":[],"label_agreement":null},{"id":"W2532432536","doi":"10.1177/1756283x16674660","title":"Everolimus in the management of metastatic neuroendocrine tumours","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Everolimus; Medicine; Pasireotide; Neuroendocrine tumors; PI3K/AKT/mTOR pathway; Temsirolimus; Oncology; Sirolimus; Internal medicine; Lanreotide; Targeted therapy; Cancer; Discovery and development of mTOR inhibitors","score_opus":0.04827955660449404,"score_gpt":0.4019686366715154,"score_spread":0.3536890800670214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532432536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017803898,0.96237224,0.0012344846,0.0076782913,0.00091738405,0.000032856482,0.000062680694,0.00006215479,0.009836085],"genre_scores_gemma":[0.22953548,0.7505064,0.003038601,0.006319694,0.0039764815,0.000066965775,0.00029019805,0.000040761883,0.0062255096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997805,0.00008142625,0.000024825174,0.000021117392,0.00007263477,0.000019654275],"domain_scores_gemma":[0.99975365,0.00008399585,0.000059909882,0.000008143072,0.000035305937,0.000058976173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056244043,0.0002529069,0.0005151316,0.0004288255,0.00013305755,0.00031187636,0.00024708983,0.00043288496,0.0009942874],"category_scores_gemma":[0.00072769873,0.000061491955,0.0003384668,0.0003405915,0.00021187041,0.00031822125,0.00027397388,0.0015488893,0.0004948638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011092339,0.00018041943,0.0014074363,0.002054197,0.00022152979,0.0021809924,0.00008126451,0.0014804195,0.0067193066,0.0029502944,0.02305595,0.9585589],"study_design_scores_gemma":[0.0013380772,0.0047677713,0.022816285,0.0037127663,0.0003758447,0.02471184,0.000148015,0.0023389065,0.006095985,0.0068192724,0.926804,0.000071169976],"about_ca_topic_score_codex":0.00050378003,"about_ca_topic_score_gemma":0.0015309105,"teacher_disagreement_score":0.0009942874,"about_ca_system_score_codex":0.00035379914,"about_ca_system_score_gemma":0.000315433,"threshold_uncertainty_score":0.0033262372},"labels":[],"label_agreement":null},{"id":"W2592982282","doi":"10.1177/1756283x17694832","title":"Insights into the role of the intestinal microbiota in colon cancer","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of New Brunswick; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Colorectal cancer; Gut flora; Immune system; Microbiome; Cancer; Organoid; Mouse model of colorectal and intestinal cancer; Biology; Medicine; Cancer research; Immunology; Bioinformatics; Internal medicine; Cell biology","score_opus":0.023567496575031564,"score_gpt":0.35722175134022693,"score_spread":0.3336542547651954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592982282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012242608,0.99814415,0.00011858442,0.000368909,0.000205451,0.0000031012205,0.000013737123,0.000005674724,0.001018016],"genre_scores_gemma":[0.0007053633,0.9984517,0.00011901495,0.00014704713,0.000118831675,0.000003251304,0.000018361663,0.0000010033357,0.00043537846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998561,0.000024689705,0.00001942949,0.000022120694,0.00005858743,0.00001901214],"domain_scores_gemma":[0.9997683,0.000087627566,0.000030637966,0.00000839924,0.000069883376,0.00003524875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045906124,0.00062498264,0.0008615641,0.0019785038,0.00032271852,0.00091035827,0.00057639333,0.0009470576,0.0036654237],"category_scores_gemma":[0.0005678564,0.00019492666,0.00040308843,0.001385253,0.00048073696,0.0012251554,0.00078398205,0.001749479,0.0019027239],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006437247,0.0000586646,0.00026349406,0.013945383,0.00006975036,0.00032498932,0.000083442195,0.00026873275,0.0033069924,0.0066658813,0.023513913,0.95143443],"study_design_scores_gemma":[0.0000090553285,0.00006155686,0.0008408198,0.0024380563,0.000056621666,0.0012442531,0.000051488576,0.00005484716,0.0005272312,0.0020304653,0.992673,0.000012657495],"about_ca_topic_score_codex":0.00083877554,"about_ca_topic_score_gemma":0.0017030768,"teacher_disagreement_score":0.0036654237,"about_ca_system_score_codex":0.00057136524,"about_ca_system_score_gemma":0.0010262326,"threshold_uncertainty_score":0.012262046},"labels":[],"label_agreement":null},{"id":"W2761609799","doi":"10.1177/1756283x17733657","title":"Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD","year":2017,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University Health Centre","funders":"","keywords":"Allopurinol; Medicine; Thiopurine methyltransferase; Pharmacology; Wound healing; Bioinformatics; Inflammatory bowel disease; Internal medicine; Surgery; Disease; Biology","score_opus":0.026669983512847686,"score_gpt":0.3637444177690611,"score_spread":0.3370744342562134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761609799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818459,0.016283618,0.00029917216,0.00008466614,0.000021768361,0.000020535394,0.00006654178,0.000020925007,0.0013567392],"genre_scores_gemma":[0.99589753,0.0034057184,0.00029666576,0.000041619158,0.000063448504,0.000008445033,0.000099864876,0.0000033892568,0.00018347354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965906,0.00009922806,0.00004613715,0.000046558645,0.00011872001,0.000030312529],"domain_scores_gemma":[0.9992599,0.00015155473,0.00041534018,0.000037545786,0.000068698486,0.0000668549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000351748,0.0001335259,0.0003808736,0.0004089228,0.0001558025,0.00025573443,0.00016851145,0.00019572489,0.0014082004],"category_scores_gemma":[0.0011135326,0.00008102811,0.00027376864,0.00047067093,0.00015495859,0.00017182792,0.00014276676,0.00020388991,0.00026592106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034319619,0.00060150685,0.74491745,0.0007886612,0.00040236718,0.003627298,0.00014678542,0.00010833284,0.03011728,0.000041686762,0.0005092967,0.21530743],"study_design_scores_gemma":[0.00009118099,0.003833085,0.9707742,0.00010411567,0.00026180167,0.017696112,0.00013532859,0.00014132546,0.004409107,0.000028599936,0.0025207016,0.0000044908343],"about_ca_topic_score_codex":0.00013054056,"about_ca_topic_score_gemma":0.00033102132,"teacher_disagreement_score":0.0014082004,"about_ca_system_score_codex":0.00014762829,"about_ca_system_score_gemma":0.000098722514,"threshold_uncertainty_score":0.004710853},"labels":[],"label_agreement":null},{"id":"W2790874308","doi":"10.1177/1756283x18757184","title":"The role of early colonoscopy in patients presenting with acute lower gastrointestinal bleeding: a systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université de Sherbrooke; McGill University Health Centre","funders":"","keywords":"Medicine; Colonoscopy; Observational study; Randomized controlled trial; Odds ratio; Meta-analysis; Adverse effect; Lower gastrointestinal bleeding; Internal medicine; Incidence (geometry); Surgery; Colorectal cancer; Cancer","score_opus":0.028547339417971634,"score_gpt":0.33106797070252475,"score_spread":0.3025206312845531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790874308","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004267913,0.9946209,0.00024883248,0.00015366396,0.0000956678,0.00015972095,0.00029073577,0.0000147137,0.00014788659],"genre_scores_gemma":[0.17596194,0.8195434,0.0017227583,0.0008795313,0.0002978671,0.00073974807,0.0006243232,0.000022014605,0.00020840733],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99100167,0.003943009,0.0030125421,0.0009031444,0.0008868268,0.0002528536],"domain_scores_gemma":[0.978803,0.015375954,0.0036860716,0.00052866916,0.0013049757,0.00030124013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011245976,0.002394503,0.018356256,0.006977335,0.0005742145,0.0031780319,0.0020683056,0.0022762248,0.0030495191],"category_scores_gemma":[0.030747505,0.0014037638,0.0349045,0.0073381914,0.00066634786,0.0018227084,0.0013591865,0.0018148412,0.00025840572],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024154948,0.000039522412,0.005921658,0.40815473,0.5700517,0.00013563466,0.00008557178,0.00036318912,0.00017017526,0.00008363752,0.0004343255,0.01214432],"study_design_scores_gemma":[0.0005225799,0.00019748714,0.0044629006,0.026802106,0.9665182,0.000096793294,0.000037683247,0.00013582945,0.0000654116,0.00010034682,0.0010393942,0.000021234662],"about_ca_topic_score_codex":0.005327112,"about_ca_topic_score_gemma":0.012945576,"teacher_disagreement_score":0.018356256,"about_ca_system_score_codex":0.002153295,"about_ca_system_score_gemma":0.0030818575,"threshold_uncertainty_score":0.059475124},"labels":[],"label_agreement":null},{"id":"W2805115131","doi":"10.1177/1756284818777938","title":"Different clinical outcomes in Crohn’s disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Crohn's disease; Ileum; Concomitant; Jejunum; Disease; Retrospective cohort study","score_opus":0.01167040709834665,"score_gpt":0.2759898635096872,"score_spread":0.2643194564113405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805115131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99964726,0.00009180839,0.000023959266,0.000014250451,0.000002709887,0.000002667849,0.00009085889,8.7133657e-7,0.00012548012],"genre_scores_gemma":[0.99970347,0.000036531772,0.000025992955,0.000007802097,0.0000063175776,0.0000048887687,0.0001856966,5.974017e-7,0.000028749884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994399,0.00014241674,0.00007159641,0.0001103314,0.000091023714,0.000144722],"domain_scores_gemma":[0.99804735,0.00041485438,0.00088749785,0.00009976018,0.00014930671,0.00040124526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007295092,0.00025303426,0.00043962663,0.0012490882,0.00050944946,0.0006766007,0.00042707883,0.00058185006,0.0017032024],"category_scores_gemma":[0.0025731677,0.00026193546,0.0005315489,0.00096599647,0.00045728846,0.00075170415,0.00063276803,0.00044372282,0.00031494437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011922913,0.000011853139,0.9992455,0.0000024153467,0.000012062023,0.00015317954,0.000024969579,0.000013609312,0.00006521291,0.0000060694947,0.000017921599,0.00032798946],"study_design_scores_gemma":[0.000012579362,0.00018206115,0.9978738,0.0000056197528,0.000021598671,0.0013348804,0.00027322015,0.000120559074,0.000054334734,0.000034875397,0.00008020908,0.000006277382],"about_ca_topic_score_codex":0.0011658048,"about_ca_topic_score_gemma":0.0012726543,"teacher_disagreement_score":0.0017032024,"about_ca_system_score_codex":0.0003876893,"about_ca_system_score_gemma":0.00028049375,"threshold_uncertainty_score":0.005697787},"labels":[],"label_agreement":null},{"id":"W2809588344","doi":"10.1177/1756284818783614","title":"Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"UCB Pharma; Sun Pharma; Takeda Oncology; Gilead Sciences; University of Chicago; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Vedolizumab; Perioperative; Surgery; Ulcerative colitis; Inflammatory bowel disease; Internal medicine; Disease","score_opus":0.01144452840463385,"score_gpt":0.28262887396106817,"score_spread":0.27118434555643434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809588344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99943787,0.0002787127,0.000092617556,0.000006966843,0.0000037982572,0.000013495806,0.000044203127,0.000001003534,0.00012140608],"genre_scores_gemma":[0.9997247,0.00007490383,0.00006132994,0.0000075495805,0.00001023589,0.000010948535,0.00007471441,8.978401e-7,0.000034665165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990451,0.00027475713,0.0001119807,0.0002800576,0.00016946322,0.00011863295],"domain_scores_gemma":[0.99831235,0.00049814343,0.00071820436,0.00018887343,0.00008604987,0.00019643774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008986519,0.0003171134,0.0005216654,0.0012161986,0.00046827918,0.0004808357,0.00043628883,0.00054284115,0.0019834747],"category_scores_gemma":[0.0024531037,0.00041283807,0.0007149401,0.00092168915,0.00033523794,0.00033440036,0.00042735413,0.00035301465,0.0001988391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001411152,0.00017521893,0.99564064,0.000019327876,0.00023207777,0.00048651997,0.000045725465,0.000040694245,0.000467107,0.00003069467,0.000047826554,0.0014030468],"study_design_scores_gemma":[0.00015362457,0.0014152133,0.994676,0.000009704019,0.0002525183,0.0021576853,0.00018962739,0.00058293296,0.00022356358,0.000040841194,0.00028895042,0.000009321493],"about_ca_topic_score_codex":0.0011363887,"about_ca_topic_score_gemma":0.0009242284,"teacher_disagreement_score":0.0019834747,"about_ca_system_score_codex":0.0002923724,"about_ca_system_score_gemma":0.00025318726,"threshold_uncertainty_score":0.006635368},"labels":[],"label_agreement":null},{"id":"W2898696583","doi":"10.1177/1756284818805597","title":"Insights into the evaluation and management of dyspepsia: recent developments and new guidelines","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epigastric pain; Proton-pump inhibitor; Internal medicine; Gastroenterology; Pill; Endoscopy; Small intestinal bacterial overgrowth; Distress; Cisapride; Irritable bowel syndrome","score_opus":0.11539051556216302,"score_gpt":0.4147446486955352,"score_spread":0.29935413313337217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898696583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038447278,0.89551103,0.0025446157,0.09081427,0.005781175,0.000079012134,0.00011339312,0.00010835681,0.0046637836],"genre_scores_gemma":[0.003230848,0.93901724,0.012446897,0.030234834,0.012597528,0.00015805638,0.0004523734,0.000054907312,0.001807313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935781,0.002354784,0.0014359725,0.0005836135,0.0017193808,0.00032810954],"domain_scores_gemma":[0.97106814,0.010847576,0.0021213645,0.0006728566,0.012606363,0.0026837515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014013671,0.001676193,0.0027995077,0.005113399,0.00086654315,0.0035721143,0.0035518997,0.0059857722,0.003983282],"category_scores_gemma":[0.029435594,0.00071599457,0.0019545169,0.004001785,0.0027403866,0.007151404,0.0025154671,0.0144786155,0.0031207693],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001368097,0.00021117057,0.00097119884,0.008666774,0.00012147583,0.0004351088,0.00036438808,0.0007637483,0.00033508855,0.007770921,0.22585748,0.7543658],"study_design_scores_gemma":[0.00012520056,0.00017158022,0.0024613857,0.04370801,0.0002629654,0.0013128298,0.00046981315,0.0006829336,0.00012840083,0.011414186,0.93918216,0.00008050689],"about_ca_topic_score_codex":0.00895909,"about_ca_topic_score_gemma":0.019414006,"teacher_disagreement_score":0.014013671,"about_ca_system_score_codex":0.0044839038,"about_ca_system_score_gemma":0.0076293107,"threshold_uncertainty_score":0.074112296},"labels":[],"label_agreement":null},{"id":"W2946059666","doi":"10.1177/1756284819851510","title":"Efficacy and safety of a ready-to-drink bowel preparation for colonoscopy: a randomized, controlled, non-inferiority trial","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Ferring Pharmaceuticals","keywords":"Medicine; Tolerability; Colonoscopy; Clinical endpoint; Adverse effect; Nausea; Randomized controlled trial; Internal medicine; Vomiting; Confidence interval; Gastroenterology; Colorectal cancer","score_opus":0.010494155378295773,"score_gpt":0.3229618172978645,"score_spread":0.3124676619195687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946059666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96252143,0.015400921,0.0025459656,0.0016417764,0.0009394639,0.013335881,0.00088154036,0.00015469737,0.002578255],"genre_scores_gemma":[0.97257644,0.0035321326,0.0056124507,0.002178344,0.0012442637,0.012815823,0.0006353817,0.00003647237,0.0013687396],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99579453,0.0027511078,0.00036956003,0.00050188287,0.00036517737,0.00021775365],"domain_scores_gemma":[0.9956232,0.001774829,0.001395456,0.00036587662,0.0002800171,0.00056068646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065817516,0.001384248,0.0031444917,0.0005156359,0.0005778973,0.0012356002,0.0011533909,0.0026545047,0.006037773],"category_scores_gemma":[0.0060132183,0.0006212019,0.002416997,0.000481781,0.001553528,0.0012024192,0.00048210195,0.0024333203,0.00073809014],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9790717,0.004811903,0.00046803552,0.0016058516,0.0012882828,0.000027169326,0.00004464214,0.00010862052,0.0019427786,0.000105101564,0.00024014503,0.010285673],"study_design_scores_gemma":[0.9548324,0.042756286,0.0008107386,0.00007544489,0.0006877612,0.000020730296,0.000010266127,0.00013644923,0.00027343477,0.00007924168,0.00030892517,0.000008458292],"about_ca_topic_score_codex":0.00027438742,"about_ca_topic_score_gemma":0.00069961086,"teacher_disagreement_score":0.0065817516,"about_ca_system_score_codex":0.0006525319,"about_ca_system_score_gemma":0.0015793255,"threshold_uncertainty_score":0.03480804},"labels":[],"label_agreement":null},{"id":"W2962999280","doi":"10.1177/1756284819863015","title":"Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Endoscopy; Histology; Gold standard (test); Inflammation; Crypt; Colorectal cancer; Pathology; Disease; Radiology; Internal medicine; Cancer","score_opus":0.006374526017557489,"score_gpt":0.27758627589576146,"score_spread":0.27121174987820396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962999280","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020026262,0.98551023,0.004819924,0.0044883233,0.0014630647,0.000019949384,0.000039703387,0.000046314046,0.0016098224],"genre_scores_gemma":[0.019718926,0.95781326,0.016015114,0.0029247121,0.002013983,0.000054711072,0.00010703106,0.000047113725,0.001305224],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997471,0.0010301449,0.00025890194,0.00029607062,0.0007962073,0.00014782236],"domain_scores_gemma":[0.99627763,0.0018423832,0.00054996036,0.00023093693,0.0009586696,0.00014030722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064701433,0.0009273779,0.002451008,0.0027768419,0.00025433625,0.0026297946,0.0011358459,0.0020787132,0.0021859154],"category_scores_gemma":[0.008318681,0.0004663399,0.00094877946,0.0018134675,0.0024488426,0.005387163,0.0011459499,0.003235662,0.0020981699],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009523079,0.00018861309,0.011598228,0.018076839,0.00052105065,0.0012705422,0.00048622338,0.00071945426,0.02104073,0.011013356,0.017712824,0.91641986],"study_design_scores_gemma":[0.00022775045,0.0022558672,0.061008982,0.016594926,0.0014534289,0.030082198,0.0027570042,0.002729493,0.021851506,0.03723042,0.8232222,0.0005861481],"about_ca_topic_score_codex":0.0013096625,"about_ca_topic_score_gemma":0.0017504692,"teacher_disagreement_score":0.0064701433,"about_ca_system_score_codex":0.00074339745,"about_ca_system_score_gemma":0.0009393167,"threshold_uncertainty_score":0.034217775},"labels":[],"label_agreement":null},{"id":"W2972047604","doi":"10.1177/1756284819870977","title":"Insights into the role of cannabis in the management of inflammatory bowel disease","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cannabidiol; Cannabis; Medicine; Inflammatory bowel disease; Endocannabinoid system; Disease; Effects of cannabis; Clinical trial; Cannabinoid; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.016359062873174013,"score_gpt":0.33174517637602485,"score_spread":0.31538611350285084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972047604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016684538,0.9984471,0.00007109997,0.00030627887,0.000091559916,0.0000035912753,0.000014682722,0.0000033779631,0.0008954383],"genre_scores_gemma":[0.0011414422,0.9982692,0.0001189122,0.00013445315,0.000087817265,0.000003897962,0.000012461149,7.950382e-7,0.00023090103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977213,0.00005149787,0.00004114411,0.000037857055,0.00007823261,0.000019163885],"domain_scores_gemma":[0.9996797,0.00020644144,0.000033546694,0.0000072752264,0.000055858312,0.000017135935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051512447,0.00051156577,0.0009638816,0.001977456,0.00032762115,0.0009345623,0.00048421678,0.0008330021,0.0041243425],"category_scores_gemma":[0.000782901,0.00018697589,0.0005978471,0.0011958578,0.00044257563,0.0007787848,0.00055184,0.0013798887,0.00088549143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010260522,0.00007877526,0.00024907084,0.034716792,0.00013732558,0.00034174143,0.0001576092,0.00028985177,0.001816239,0.0052764867,0.011407585,0.9454259],"study_design_scores_gemma":[0.000033934073,0.00015691959,0.0019374868,0.016355757,0.00024661035,0.0025266304,0.0001767216,0.00016439214,0.0006738789,0.004705714,0.9729916,0.00003021278],"about_ca_topic_score_codex":0.001775057,"about_ca_topic_score_gemma":0.0040100897,"teacher_disagreement_score":0.0041243425,"about_ca_system_score_codex":0.0005448857,"about_ca_system_score_gemma":0.0011684223,"threshold_uncertainty_score":0.013797283},"labels":[],"label_agreement":null},{"id":"W2974496516","doi":"10.1177/1756284819870911","title":"Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Medicine; Inflammatory bowel disease; Gut flora; Immune system; Diarrhea; Colitis; Immunology; Disease; Discontinuation; Gastroenterology; Internal medicine","score_opus":0.022655417149853432,"score_gpt":0.3423823525466908,"score_spread":0.3197269353968374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974496516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022132296,0.9979055,0.00008077646,0.00032235793,0.00022263188,0.0000036470296,0.000023702758,0.0000068678455,0.0012131113],"genre_scores_gemma":[0.0009143778,0.99798846,0.000112848145,0.00019699956,0.00013035849,0.0000048219513,0.000026581072,0.0000012295066,0.0006242444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998913,0.000020436551,0.000015259995,0.000016957578,0.00004293245,0.000013155239],"domain_scores_gemma":[0.9998729,0.00005163644,0.000022187662,0.0000031255126,0.000036547342,0.000013503934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002603445,0.00049466453,0.00083528884,0.0011093937,0.00019967486,0.0007053024,0.00041253003,0.00074274495,0.0031880462],"category_scores_gemma":[0.00039349587,0.00013285658,0.0003937803,0.000995387,0.00018805958,0.00059261784,0.00050457637,0.0010063383,0.0015320801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000806028,0.00005044013,0.00018469986,0.014111495,0.00007545527,0.000205936,0.00004076901,0.00019502165,0.002265577,0.0019780973,0.023789564,0.9570223],"study_design_scores_gemma":[0.000019641648,0.000121757956,0.001354162,0.0045293085,0.00013219335,0.0017619242,0.000055416953,0.00007473599,0.0006530604,0.0011501418,0.9901327,0.000014895797],"about_ca_topic_score_codex":0.0006563985,"about_ca_topic_score_gemma":0.0013691044,"teacher_disagreement_score":0.0031880462,"about_ca_system_score_codex":0.00037077113,"about_ca_system_score_gemma":0.00062793633,"threshold_uncertainty_score":0.010665059},"labels":[],"label_agreement":null},{"id":"W3001750915","doi":"10.1177/1756284819897531","title":"Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Infant Health and Development","field":"Health Professions","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Salix Pharmaceuticals","keywords":"Rifaximin; Irritable bowel syndrome; Medicine; Small intestinal bacterial overgrowth; Gastroenterology; Internal medicine; Gut flora; Context (archaeology); Intestinal permeability; Diarrhea; Abdominal pain; Antibiotics; Immunology","score_opus":0.0418792466789998,"score_gpt":0.39903775116272167,"score_spread":0.3571585044837219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001750915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006236713,0.9994892,0.000024020012,0.0001643376,0.000080676975,0.000006133675,0.000018069632,0.0000014104357,0.00015382816],"genre_scores_gemma":[0.0008496676,0.9985868,0.000070654365,0.00024297113,0.00014443873,0.000013118532,0.000022949382,6.5140455e-7,0.00006872518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995951,0.000105266095,0.00013726654,0.00006183844,0.0000775102,0.000023027129],"domain_scores_gemma":[0.99825746,0.0011902845,0.00033120075,0.000019596617,0.00016354835,0.000037947284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010688056,0.0008453514,0.0020822543,0.0019780584,0.00026113132,0.001356243,0.00095381576,0.0013063549,0.0038507513],"category_scores_gemma":[0.0032003804,0.0002647876,0.0013768262,0.0019091953,0.00041530034,0.0013124157,0.000622028,0.0011505033,0.0005970118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033764256,0.00005321885,0.0003632801,0.36016104,0.00088600826,0.00030048672,0.0001602439,0.0002581669,0.00059609534,0.0023102835,0.02173667,0.6128369],"study_design_scores_gemma":[0.00021527843,0.00048360473,0.0033128632,0.26804033,0.0060091577,0.0035580378,0.0003245674,0.00023556023,0.00051494385,0.0023335037,0.7149026,0.00006970183],"about_ca_topic_score_codex":0.00088492,"about_ca_topic_score_gemma":0.0013955673,"teacher_disagreement_score":0.0038507513,"about_ca_system_score_codex":0.00057068816,"about_ca_system_score_gemma":0.0014990646,"threshold_uncertainty_score":0.012882054},"labels":[],"label_agreement":null},{"id":"W3004927985","doi":"10.1177/1756284820902878","title":"Efficacy, safety, and tolerability of a ready-to-drink bowel preparation: subanalysis by age from a phase III, assessor-blinded study","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Ferring","keywords":"Tolerability; Medicine; Colonoscopy; Adverse effect; Internal medicine; Post-hoc analysis; Clinical endpoint; Randomized controlled trial; Gastroenterology; Colorectal cancer; Cancer","score_opus":0.033024671102554616,"score_gpt":0.3610694429592313,"score_spread":0.3280447718566767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004927985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97481245,0.006833668,0.0042107976,0.0002989969,0.00037762424,0.010227102,0.0016546826,0.00010863777,0.0014759738],"genre_scores_gemma":[0.98022467,0.0017593037,0.00390073,0.0008980932,0.00042877247,0.010424694,0.0011302577,0.000049960607,0.0011836287],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9931896,0.00412758,0.00082143827,0.00065081957,0.0007460907,0.00046452577],"domain_scores_gemma":[0.98883677,0.0037402872,0.003403729,0.0016819105,0.0013996894,0.0009376162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016748974,0.0017095341,0.004196577,0.0004282811,0.0005395434,0.0013394743,0.00094188115,0.0015399298,0.0034862144],"category_scores_gemma":[0.010674867,0.0005666542,0.005979386,0.0006300873,0.0014245829,0.0011888213,0.00058558123,0.0020478151,0.000545658],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95543134,0.008624447,0.004069402,0.0014278127,0.008377899,0.000052198957,0.00015700204,0.000436304,0.008190388,0.000082037826,0.0005888116,0.012562398],"study_design_scores_gemma":[0.5568066,0.39553958,0.029390331,0.00015054665,0.011396335,0.00010666645,0.00010276695,0.0008985223,0.0031723399,0.0003225699,0.0020551607,0.00005861205],"about_ca_topic_score_codex":0.00041086032,"about_ca_topic_score_gemma":0.0009186425,"teacher_disagreement_score":0.016748974,"about_ca_system_score_codex":0.000815371,"about_ca_system_score_gemma":0.0019916072,"threshold_uncertainty_score":0.088578105},"labels":[],"label_agreement":null},{"id":"W3015999147","doi":"10.1177/1756284820910050","title":"Efficacy, safety, and tolerability of a ready-to-drink bowel preparation in overweight and obese adults: subanalysis by body mass index from a phase III, assessor-blinded study","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Ferring","keywords":"Tolerability; Medicine; Overweight; Body mass index; Internal medicine; Clinical endpoint; Adverse effect; Underweight; Post-hoc analysis; Gastroenterology; Randomized controlled trial","score_opus":0.015413100651675324,"score_gpt":0.33016381846527304,"score_spread":0.3147507178135977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015999147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887543,0.0038363102,0.0019002329,0.00014902429,0.00010241938,0.0037336135,0.000772746,0.00004493576,0.00070635614],"genre_scores_gemma":[0.9917395,0.0010689219,0.0019684841,0.00047305544,0.00017451473,0.0032984319,0.00081162615,0.00002738955,0.00043800907],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99634796,0.0020930085,0.0005222351,0.00033656316,0.0004794978,0.00022077173],"domain_scores_gemma":[0.99353975,0.0020094737,0.0022139412,0.0009503943,0.00062665966,0.0006597947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010747399,0.0010191726,0.0026382955,0.00038797568,0.00041853025,0.0009593497,0.00069246517,0.000920204,0.0025908414],"category_scores_gemma":[0.006601241,0.00043688755,0.0038180253,0.00051127473,0.001015987,0.00076391303,0.0004833024,0.0014481104,0.0003491106],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90058684,0.011178009,0.022731822,0.0020507728,0.01090924,0.00008185286,0.00025470194,0.00051955605,0.021491352,0.00008423091,0.00072369585,0.029388022],"study_design_scores_gemma":[0.43145207,0.42369896,0.1200833,0.00018061724,0.013666692,0.00026166727,0.00015100109,0.001009919,0.0066340864,0.0002350706,0.0025559065,0.000070678034],"about_ca_topic_score_codex":0.00026168136,"about_ca_topic_score_gemma":0.00069894636,"teacher_disagreement_score":0.010747399,"about_ca_system_score_codex":0.0005219519,"about_ca_system_score_gemma":0.001327349,"threshold_uncertainty_score":0.056838393},"labels":[],"label_agreement":null},{"id":"W3024086321","doi":"10.1177/1756284820922746","title":"Optical evaluation: the crux for effective management of colorectal neoplasia","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Endoscopic submucosal dissection; Endoscopic mucosal resection; Colorectal cancer; Resection; Dissection (medical); Colorectal Polyp; Colonoscopy; Surgery; General surgery; Radiology; Cancer; Internal medicine","score_opus":0.0360485543058619,"score_gpt":0.3842003311822021,"score_spread":0.3481517768763402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024086321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043446587,0.9989273,0.00007534331,0.0005262214,0.000098387914,0.000001833424,0.000004986559,0.0000028970785,0.00031959845],"genre_scores_gemma":[0.00066905137,0.9983675,0.00021731795,0.0003873858,0.0001886543,0.0000033184717,0.000011077102,0.0000013270753,0.00015436848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999491,0.00015696135,0.000082325714,0.0000654836,0.00017230531,0.000031901378],"domain_scores_gemma":[0.99847776,0.0010020701,0.00014958835,0.000039622413,0.00028115168,0.000049803733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013863193,0.0006476982,0.0015680447,0.0016102638,0.0002367973,0.001252912,0.0007611321,0.0012307245,0.0032684668],"category_scores_gemma":[0.0023790754,0.00021724305,0.0009258156,0.0012403842,0.0008319676,0.0022134485,0.00063249335,0.0028332274,0.0011702441],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006917361,0.000029704393,0.00020501681,0.022929324,0.0001269959,0.00012370363,0.00004254386,0.00013729907,0.000601912,0.0036211594,0.015882604,0.95623064],"study_design_scores_gemma":[0.000031939126,0.00015912492,0.002162888,0.03258667,0.00036777157,0.0023563465,0.00014720974,0.00015319511,0.00043007042,0.005809717,0.9557587,0.000036431404],"about_ca_topic_score_codex":0.0012184376,"about_ca_topic_score_gemma":0.0021267384,"teacher_disagreement_score":0.0032684668,"about_ca_system_score_codex":0.0006780402,"about_ca_system_score_gemma":0.001354959,"threshold_uncertainty_score":0.010934174},"labels":[],"label_agreement":null},{"id":"W3031965734","doi":"10.1177/1756284820927550","title":"Complementary and alternative medications in the management of inflammatory bowel disease","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Intensive care medicine; Disease; Narrative review; Crohn's disease; Alternative medicine; Ulcerative colitis; Drug; Internal medicine; Pharmacology; Pathology","score_opus":0.046080959107641685,"score_gpt":0.3873131602752891,"score_spread":0.3412322011676474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031965734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000090345915,0.99885833,0.00003852381,0.00015003448,0.00008884587,0.0000073501474,0.000017026567,0.0000025544784,0.0007469709],"genre_scores_gemma":[0.0009809218,0.9983682,0.00016749713,0.0001527119,0.00007996082,0.0000075078383,0.000021303156,7.073287e-7,0.00022124976],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994211,0.00019482801,0.0001078879,0.000059964997,0.00018384094,0.000032364856],"domain_scores_gemma":[0.9992428,0.0004931203,0.00012190268,0.000014330227,0.00010503959,0.000022912873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069561915,0.0006365263,0.0011100867,0.0027815916,0.00032002723,0.0011447726,0.00050266937,0.00088899134,0.0071180305],"category_scores_gemma":[0.001646759,0.00017135312,0.0010146028,0.002471588,0.0003710236,0.0008005186,0.0006674461,0.0012280295,0.0011356415],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090062436,0.000070404,0.0002126248,0.10003868,0.00034154972,0.00018984226,0.00013570739,0.0001845698,0.00070615386,0.0027566475,0.013426407,0.8818473],"study_design_scores_gemma":[0.00005092724,0.00017309259,0.0024195665,0.083239324,0.0009644309,0.0021223985,0.00019509807,0.0001120822,0.00036802003,0.0027270322,0.9076003,0.000027800876],"about_ca_topic_score_codex":0.0015932727,"about_ca_topic_score_gemma":0.0038168503,"teacher_disagreement_score":0.0071180305,"about_ca_system_score_codex":0.00053309544,"about_ca_system_score_gemma":0.0013725583,"threshold_uncertainty_score":0.023812115},"labels":[],"label_agreement":null},{"id":"W3094596778","doi":"10.1177/1756284820961299","title":"Berberine for diarrhea in children and adults: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Berberine and alkaloids research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Key Research and Development Program of China Stem Cell and Translational Research","keywords":"Medicine; Diarrhea; Berberine; Internal medicine; Randomized controlled trial; Clinical trial; Antibiotic-associated diarrhea; Pediatrics; Antibiotics; Pharmacology","score_opus":0.042374588407488305,"score_gpt":0.3862551853325447,"score_spread":0.3438805969250564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094596778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004540446,0.99436945,0.00014068022,0.00011630477,0.00007227219,0.00018949973,0.00036017565,0.00001080478,0.00020033626],"genre_scores_gemma":[0.111085854,0.88537663,0.0010051808,0.0006977381,0.00019290987,0.0007533951,0.0006046741,0.000014035916,0.0002696048],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957605,0.0017938726,0.0012342212,0.00047982374,0.0005077861,0.00022384894],"domain_scores_gemma":[0.9908461,0.006425107,0.0017691926,0.00019363037,0.0005871797,0.00017886992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062377965,0.0019804018,0.01626573,0.0042752703,0.000596621,0.0024535672,0.0016278157,0.0019498504,0.0043022344],"category_scores_gemma":[0.014240655,0.0010124616,0.025975974,0.0055782082,0.0005487378,0.0015838161,0.00119123,0.001716426,0.00023404296],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048519596,0.000075945594,0.003816598,0.63490766,0.33644348,0.00016357165,0.00009296923,0.00038328732,0.00021675468,0.00013177376,0.0009285927,0.01798747],"study_design_scores_gemma":[0.0020580573,0.0005287419,0.0063944687,0.0545402,0.9327655,0.00015468498,0.0000729109,0.0002060865,0.00012667822,0.00015971017,0.0029614582,0.000031493037],"about_ca_topic_score_codex":0.0059934543,"about_ca_topic_score_gemma":0.014859348,"teacher_disagreement_score":0.01626573,"about_ca_system_score_codex":0.0020042735,"about_ca_system_score_gemma":0.0028120084,"threshold_uncertainty_score":0.032988966},"labels":[],"label_agreement":null},{"id":"W3106878288","doi":"10.1177/1756284820968732","title":"Classifying Crohn’s disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Internal medicine; Hazard ratio; Gastroenterology; Odds ratio; Interquartile range; Crohn's disease; Disease; Azathioprine; Colectomy; Retrospective cohort study; Confidence interval; Inflammatory bowel disease; Ulcerative colitis","score_opus":0.031577677813218984,"score_gpt":0.320503417605627,"score_spread":0.28892573979240804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106878288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700326,0.0007320939,0.00027664963,0.0001785796,0.000023439407,0.000020018027,0.0002916938,0.0000077555305,0.001466495],"genre_scores_gemma":[0.99900025,0.00014923107,0.0003432231,0.00002425166,0.000033690776,0.000006363801,0.00029417741,0.0000023908517,0.00014645176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999295,0.00020176532,0.000089211666,0.00012886825,0.00016277212,0.0001223486],"domain_scores_gemma":[0.99560887,0.0006051946,0.0024597575,0.0001547642,0.00037723742,0.00079422357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009642357,0.00042006557,0.0003294632,0.0011500135,0.00046821177,0.00079851376,0.0003437105,0.00044341708,0.0036303198],"category_scores_gemma":[0.0034515336,0.00013717964,0.00047574998,0.001034828,0.00046756217,0.00062043645,0.00053330127,0.0004586481,0.00042003114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106949636,0.0000085329375,0.9985617,0.000009133863,0.000020813486,0.000032480995,0.000015741047,0.000022787204,0.00014691333,0.000008922032,0.00008512671,0.0009810164],"study_design_scores_gemma":[0.000008608102,0.000118115764,0.99881905,0.000016762318,0.000027014377,0.00038379245,0.00009545414,0.00020446836,0.00005564515,0.00002833354,0.00023870148,0.000003864989],"about_ca_topic_score_codex":0.0059940424,"about_ca_topic_score_gemma":0.0094533935,"teacher_disagreement_score":0.0059940424,"about_ca_system_score_codex":0.00046417894,"about_ca_system_score_gemma":0.00047439148,"threshold_uncertainty_score":0.012144625},"labels":[],"label_agreement":null},{"id":"W3107857591","doi":"10.1177/1756284820959252","title":"Genetic risk factors predict disease progression in Crohn’s disease patients of the Swiss inflammatory bowel disease cohort","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Inflammatory bowel disease; Disease; Crohn's disease; Cohort; Ulcerative colitis; Internal medicine; Immunology; Gastroenterology","score_opus":0.004782532001545085,"score_gpt":0.23344268776446134,"score_spread":0.22866015576291626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107857591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99959415,0.00003588302,0.000052950454,0.000021673843,0.0000013640681,0.0000023246107,0.00020533724,0.0000022828035,0.00008405063],"genre_scores_gemma":[0.9994204,0.000027067994,0.00004638375,0.0000044464596,0.0000030702006,0.0000042439337,0.00043762047,0.000001068315,0.00005579964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983263,0.000049862185,0.000011758618,0.000045205445,0.000027053526,0.000033391203],"domain_scores_gemma":[0.9992316,0.00024475323,0.00025571516,0.00008426321,0.000059552396,0.00012414614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046216854,0.00031293608,0.00019157336,0.0005405961,0.00033270926,0.00038437193,0.00017447279,0.00035951825,0.0018460414],"category_scores_gemma":[0.0013975832,0.00017018223,0.00050220574,0.00043834426,0.00016009776,0.00017051765,0.00028147936,0.00035411044,0.0001618923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029536025,0.000017667851,0.99790597,0.0000037618317,0.00003992706,0.000095939926,0.000044589582,0.0003896828,0.00036463205,0.000022248352,0.000121607205,0.0006985639],"study_design_scores_gemma":[0.000026720681,0.00008606815,0.996789,0.0000055215282,0.000038556904,0.00024977882,0.000070296905,0.0024457793,0.000082435734,0.00006200445,0.00013991655,0.0000040480977],"about_ca_topic_score_codex":0.010985399,"about_ca_topic_score_gemma":0.010035973,"teacher_disagreement_score":0.010985399,"about_ca_system_score_codex":0.0003104681,"about_ca_system_score_gemma":0.00038086833,"threshold_uncertainty_score":0.021842897},"labels":[],"label_agreement":null},{"id":"W3156991610","doi":"10.1177/17562848211006672","title":"Relevance of monitoring transmural disease activity in patients with Crohn’s disease: current status and future perspectives","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Calprotectin; Crohn's disease; Ulcerative colitis; Disease; Inflammatory bowel disease; Inflammation; Magnetic resonance imaging; Internal medicine; Gastroenterology; Radiology","score_opus":0.009323395437941326,"score_gpt":0.2953765019398923,"score_spread":0.286053106501951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156991610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001796163,0.9981864,0.000080858794,0.0010769735,0.00013925879,0.0000033146441,0.000014575883,0.000002783403,0.00031619053],"genre_scores_gemma":[0.00386106,0.99403,0.00042735893,0.000761919,0.00076291594,0.000016961012,0.000039126182,0.0000023160312,0.00009844824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986305,0.00055736216,0.00025852968,0.00018692811,0.00029960065,0.000067047426],"domain_scores_gemma":[0.9919693,0.005652218,0.00074847846,0.00009572619,0.0013089698,0.00022534638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004140219,0.00059430796,0.0024728712,0.0010876484,0.00024781178,0.0021339718,0.0011626026,0.0017651671,0.0024879563],"category_scores_gemma":[0.005641202,0.00025576,0.0011606424,0.001552915,0.0009377183,0.0022944827,0.000644199,0.0022685316,0.0007282062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043643682,0.00010213416,0.0022720087,0.03765227,0.00030126362,0.00021484353,0.00018338446,0.00025897758,0.0006500726,0.0028868783,0.01141297,0.9436288],"study_design_scores_gemma":[0.0003432648,0.0015896673,0.017711828,0.07528029,0.002670596,0.0037924254,0.001162563,0.0009843677,0.0008740732,0.011060669,0.88434833,0.00018186671],"about_ca_topic_score_codex":0.00092112727,"about_ca_topic_score_gemma":0.0016813827,"teacher_disagreement_score":0.004140219,"about_ca_system_score_codex":0.000621817,"about_ca_system_score_gemma":0.0023947125,"threshold_uncertainty_score":0.021895826},"labels":[],"label_agreement":null},{"id":"W3173320048","doi":"10.1177/17562848211004839","title":"Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn’s disease","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk Fonden","keywords":"Medicine; Relative risk; Internal medicine; Gastroenterology; Subgroup analysis; Meta-analysis; Confidence interval; Disease; Crohn's disease; Inflammatory bowel disease","score_opus":0.012729716671526215,"score_gpt":0.2971758824145549,"score_spread":0.28444616574302867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173320048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053301593,0.9922552,0.0007205538,0.00029272892,0.00021560158,0.00021174466,0.0006595166,0.000030082112,0.00028445164],"genre_scores_gemma":[0.32860437,0.66214406,0.0037886507,0.0015310788,0.0005430546,0.0015057713,0.001358111,0.000058598063,0.00046632384],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9773591,0.012462752,0.0054672593,0.002190755,0.0019073421,0.0006127658],"domain_scores_gemma":[0.95174986,0.038051967,0.006107479,0.001498133,0.0021432522,0.00044929524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02098061,0.0031395124,0.020127833,0.007828801,0.0007923609,0.004234818,0.0025399947,0.002721543,0.0037877543],"category_scores_gemma":[0.053031225,0.001573369,0.046010137,0.009748212,0.00097365695,0.0024380626,0.0019171478,0.002245969,0.00034257438],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010396587,0.000012668021,0.008030497,0.23242599,0.7526374,0.00014544728,0.000058234004,0.00045888012,0.00013124762,0.00011283111,0.0004410762,0.0045061163],"study_design_scores_gemma":[0.00029233377,0.000090637084,0.0040841023,0.01615895,0.97794807,0.000094574665,0.000031471314,0.00020545238,0.000057752382,0.00015885958,0.0008618158,0.000015965976],"about_ca_topic_score_codex":0.008173324,"about_ca_topic_score_gemma":0.0152944075,"teacher_disagreement_score":0.02098061,"about_ca_system_score_codex":0.002517805,"about_ca_system_score_gemma":0.0036837116,"threshold_uncertainty_score":0.110957384},"labels":[],"label_agreement":null},{"id":"W3186595652","doi":"10.1177/17562848211031388","title":"Early cholangioscopy-assisted electrohydraulic lithotripsy in difficult biliary stones is cost-effective","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cost effectiveness; Lithotripsy; Surgery; Risk analysis (engineering)","score_opus":0.012150891076080842,"score_gpt":0.3034157697178832,"score_spread":0.29126487864180234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186595652","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42266223,0.5068656,0.030718846,0.014256009,0.0006091485,0.0014956619,0.0068867803,0.00019428233,0.016311403],"genre_scores_gemma":[0.9620882,0.029806167,0.0058574886,0.00090635003,0.000120039746,0.00025443503,0.0006531669,0.000013379522,0.00030076422],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99404496,0.0040594717,0.0005743767,0.00038066422,0.00062595966,0.00031468837],"domain_scores_gemma":[0.9650675,0.029721921,0.0036094103,0.00036553977,0.00075792323,0.00047773178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063101863,0.00076568144,0.002006861,0.0018046388,0.00018726959,0.00180619,0.00073981157,0.001116506,0.004411288],"category_scores_gemma":[0.030469878,0.0004859459,0.0073989467,0.001786187,0.00044074972,0.0015284263,0.0008872861,0.0014024642,0.00016843484],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018893495,0.0011715434,0.1296025,0.07600401,0.05727158,0.0009507768,0.00017855855,0.18829714,0.0013852951,0.010682198,0.0074279057,0.5081349],"study_design_scores_gemma":[0.023588588,0.023743562,0.36447304,0.05614849,0.18787311,0.005998952,0.00094941095,0.22879742,0.0048745023,0.060086086,0.042880826,0.0005860402],"about_ca_topic_score_codex":0.0060922992,"about_ca_topic_score_gemma":0.007956028,"teacher_disagreement_score":0.0063101863,"about_ca_system_score_codex":0.0033209345,"about_ca_system_score_gemma":0.004011884,"threshold_uncertainty_score":0.033371806},"labels":[],"label_agreement":null},{"id":"W3197157325","doi":"10.1177/17562848211036456","title":"Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Pharmaceutical Company","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Infliximab; Population; Concomitant; Inflammatory bowel disease; Observational study; Clinical trial; Disease","score_opus":0.012821596446894292,"score_gpt":0.26167320620898954,"score_spread":0.24885160976209525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197157325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999448,0.0001529497,0.000035174406,0.000014230202,0.0000024405167,0.000011646475,0.00021185366,0.0000010467902,0.000122767],"genre_scores_gemma":[0.9992156,0.000073681316,0.000045735458,0.000026871621,0.0000070508872,0.000014002933,0.0005602886,0.0000010293159,0.000055765013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951077,0.0001345413,0.00008234022,0.00012771261,0.00007919366,0.00006543951],"domain_scores_gemma":[0.99873656,0.00014846456,0.0006938425,0.000076320386,0.00007127974,0.00027353285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007097425,0.0002753534,0.00048462034,0.0006336768,0.00032891336,0.0007261259,0.00024935562,0.0005240226,0.000986673],"category_scores_gemma":[0.0014927023,0.00029616768,0.0005123612,0.0006843559,0.00026228107,0.0005982524,0.00048570024,0.00043328563,0.00020886179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007071478,0.00009578756,0.9979634,0.00001406831,0.000072171286,0.00009421945,0.000058250214,0.00003105431,0.0002346302,0.000007902564,0.000055767145,0.0006655411],"study_design_scores_gemma":[0.00006347255,0.00031456165,0.9989398,0.0000041140506,0.000027366168,0.00032128475,0.00010762862,0.00007514011,0.000024800991,0.0000069842745,0.000110851695,0.0000039591087],"about_ca_topic_score_codex":0.0007359918,"about_ca_topic_score_gemma":0.00077380915,"teacher_disagreement_score":0.000986673,"about_ca_system_score_codex":0.00021827183,"about_ca_system_score_gemma":0.00020281575,"threshold_uncertainty_score":0.003753543},"labels":[],"label_agreement":null},{"id":"W3207078983","doi":"10.1177/17562848211048127","title":"Defining the black box: a narrative review of factors associated with adverse outcomes from severe <i>Clostridioides difficile</i> infection","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Michigan Institute for Clinical and Health Research; Agency for Healthcare Research and Quality","keywords":"Medicine; Clostridioides; Intensive care medicine; Disease; Adverse effect; Epidemiology; Metronidazole; Narrative review; Bioinformatics; Internal medicine; Antibiotics","score_opus":0.03973843512947874,"score_gpt":0.3547897648388154,"score_spread":0.3150513297093367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207078983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007426794,0.9989472,0.000040960007,0.00042258564,0.00018419712,0.000005731272,0.00004117828,0.000002763439,0.0002811734],"genre_scores_gemma":[0.0006410367,0.9984295,0.00009712602,0.00045913688,0.00018992211,0.000010623091,0.000046836423,0.0000011541746,0.00012468993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939203,0.00018311728,0.00018482738,0.00007380236,0.00013325649,0.000032898573],"domain_scores_gemma":[0.99741,0.0017401441,0.0004281944,0.000031652653,0.0003311147,0.000058956266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001163925,0.0008061028,0.0017781241,0.003391517,0.0003033992,0.001365262,0.00083838083,0.0011043719,0.003891594],"category_scores_gemma":[0.0050896355,0.00029423446,0.0012851898,0.0036522124,0.00042166392,0.001634163,0.0007880248,0.0011979943,0.00076360954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019253243,0.000039646755,0.0005880501,0.2749096,0.00069571764,0.00046869853,0.00030696546,0.00027853332,0.00053732144,0.0035993487,0.068430685,0.64995295],"study_design_scores_gemma":[0.00004610716,0.00015992616,0.002763876,0.19848041,0.0018325528,0.0032285042,0.00028880933,0.00010305039,0.0002347863,0.0019495289,0.7908597,0.000052836112],"about_ca_topic_score_codex":0.0020227712,"about_ca_topic_score_gemma":0.0037412487,"teacher_disagreement_score":0.003891594,"about_ca_system_score_codex":0.00086192176,"about_ca_system_score_gemma":0.0030022243,"threshold_uncertainty_score":0.013018668},"labels":[],"label_agreement":null},{"id":"W4205369309","doi":"10.1177/17562848211059954","title":"Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Tumor necrosis factor alpha; Necrosis; Disease; Crohn's disease; Pathology; Internal medicine","score_opus":0.01287823099216795,"score_gpt":0.2917702193540052,"score_spread":0.27889198836183726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205369309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045995057,0.9982602,0.00004328718,0.00064934517,0.00039793868,0.0000014851634,0.00000809845,0.000005375754,0.00058834214],"genre_scores_gemma":[0.00036760548,0.998145,0.00006788604,0.0004924879,0.00037468108,0.0000023600805,0.000015446385,0.0000017326199,0.00053278496],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997414,0.00005991846,0.000029602332,0.000036001802,0.00010338744,0.00002970853],"domain_scores_gemma":[0.9992937,0.00039631868,0.00006498143,0.00002030002,0.00016300693,0.000061763334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074296934,0.00072719646,0.0013210997,0.0012467466,0.0002805379,0.0013678313,0.00073125353,0.0014112984,0.00425552],"category_scores_gemma":[0.0012510051,0.000195306,0.0005602364,0.0017110672,0.0005657085,0.0020756866,0.0006499602,0.0028729541,0.0027195895],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011718498,0.000051578092,0.00012673798,0.0126975,0.000078896075,0.00016741082,0.000069913716,0.00022844235,0.0009023307,0.0049378923,0.07518679,0.9054354],"study_design_scores_gemma":[0.00001550146,0.00006634566,0.00031823938,0.0028279528,0.00005380558,0.00069515506,0.000037965812,0.00003613018,0.00011407926,0.0019149015,0.99391043,0.000009500682],"about_ca_topic_score_codex":0.00075015594,"about_ca_topic_score_gemma":0.0012952146,"teacher_disagreement_score":0.00425552,"about_ca_system_score_codex":0.00062369375,"about_ca_system_score_gemma":0.001193102,"threshold_uncertainty_score":0.014236152},"labels":[],"label_agreement":null},{"id":"W4225899336","doi":"10.1177/17562848221092594","title":"Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Birmingham Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Chromoendoscopy; Medicine; Endoscope; Endoscopy; Ulcerative colitis; Confidence interval; Internal medicine; Meta-analysis; Histology; Gastroenterology; Radiology; Colonoscopy; Colorectal cancer; Cancer; Disease","score_opus":0.0841974630530313,"score_gpt":0.4115164458532533,"score_spread":0.327318982800222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225899336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033038196,0.99544334,0.00033203818,0.00010638042,0.00006917403,0.00022352148,0.00036703644,0.000014314729,0.00014029675],"genre_scores_gemma":[0.13385603,0.8606363,0.0023593206,0.00060512644,0.00023374731,0.0012318066,0.00082736067,0.000023569624,0.0002268404],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98715615,0.00589992,0.0038406383,0.0012709171,0.0014689586,0.0003633898],"domain_scores_gemma":[0.9639981,0.02646702,0.0060798004,0.0009384543,0.0021525912,0.00036405004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015845725,0.002738667,0.018628228,0.009195544,0.0006881187,0.0034302056,0.0022576572,0.0023337645,0.0031625768],"category_scores_gemma":[0.04190048,0.0014199195,0.034640454,0.010598084,0.0008488666,0.00215633,0.0017711703,0.0016778448,0.000305197],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014007151,0.00002376143,0.0085097505,0.5043342,0.47210684,0.00012996129,0.000093453295,0.00041647386,0.00017467767,0.00009366511,0.00052723003,0.012189264],"study_design_scores_gemma":[0.00038022434,0.00018914547,0.0068421885,0.044660915,0.9461015,0.00013016797,0.00005650059,0.00019541348,0.00008738165,0.00012878688,0.0011994198,0.00002833633],"about_ca_topic_score_codex":0.0065442696,"about_ca_topic_score_gemma":0.0153715685,"teacher_disagreement_score":0.018628228,"about_ca_system_score_codex":0.0026485112,"about_ca_system_score_gemma":0.0038069007,"threshold_uncertainty_score":0.08380121},"labels":[],"label_agreement":null},{"id":"W4285238373","doi":"10.1177/17562848221102679","title":"Management of hepatorenal syndrome in liver cirrhosis: a recent update","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Terlipressin; Hepatorenal syndrome; Medicine; Cirrhosis; Acute kidney injury; Liver transplantation; Ascites; Internal medicine; Intensive care medicine; Cardiorenal syndrome; Spontaneous bacterial peritonitis; Gastroenterology; Renal replacement therapy; Transplantation; Renal function","score_opus":0.0369236797759472,"score_gpt":0.332425439785549,"score_spread":0.2955017600096018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285238373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003514447,0.9957877,0.00021541382,0.0019127929,0.0008337586,0.000011536513,0.0000422315,0.00001698381,0.0008281137],"genre_scores_gemma":[0.0017677351,0.9932243,0.0006384006,0.001425478,0.0023931544,0.00002476715,0.00016751334,0.000005988634,0.00035264186],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952316,0.00011770611,0.00011860056,0.00007470733,0.00012511207,0.00004077645],"domain_scores_gemma":[0.99798596,0.0009291642,0.00030064938,0.000035656907,0.0005469518,0.00020171674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010373994,0.00096624135,0.001793621,0.002395589,0.00035960771,0.0011867344,0.0013508615,0.0016704084,0.004022012],"category_scores_gemma":[0.0025581585,0.00024515035,0.0010050102,0.0017828462,0.00059540704,0.002054634,0.0008480468,0.0028507323,0.0011936249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013023095,0.000119304175,0.0006632648,0.008700013,0.00011516331,0.00038203556,0.00005709044,0.0003416207,0.0002390909,0.0008710481,0.046682376,0.94169885],"study_design_scores_gemma":[0.00014225321,0.00043310304,0.005494983,0.02684057,0.0007498952,0.008056515,0.0002519252,0.00053536956,0.00028367018,0.0021017776,0.95503205,0.00007787795],"about_ca_topic_score_codex":0.0019184529,"about_ca_topic_score_gemma":0.0045170533,"teacher_disagreement_score":0.004022012,"about_ca_system_score_codex":0.001003764,"about_ca_system_score_gemma":0.001236266,"threshold_uncertainty_score":0.013454914},"labels":[],"label_agreement":null},{"id":"W4285281009","doi":"10.1177/17562848221102307","title":"The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Poisson regression; Internal medicine; Ulcerative colitis; Confidence interval; Population; Disease burden; Disease; Gastroenterology; Pediatrics; Environmental health","score_opus":0.003936983264950322,"score_gpt":0.24246385636152176,"score_spread":0.23852687309657145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285281009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139506,0.0008450742,0.00014929581,0.00038182165,0.000022061387,0.000033587665,0.0062661166,0.000013476227,0.00089340995],"genre_scores_gemma":[0.99358034,0.0005986235,0.00011511473,0.00013036994,0.000028724473,0.000041808173,0.005259654,0.0000034458503,0.00024185906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946684,0.000057459165,0.000110404486,0.00010907349,0.00013253403,0.00012372865],"domain_scores_gemma":[0.9990792,0.00004701611,0.00032669748,0.000057368783,0.00027047674,0.00021918502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081406796,0.0003371477,0.00043012816,0.0013513912,0.00048917654,0.0004911995,0.0005077936,0.0002705671,0.0008816612],"category_scores_gemma":[0.0012361495,0.0002814568,0.0007052772,0.0025229682,0.00027008,0.00062163064,0.00080322626,0.0004188414,0.00011448371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029047893,0.000011938171,0.99727446,0.000041859614,0.00005628214,0.000075522985,0.00011091445,0.00007580925,0.00008642986,0.000034853583,0.00057581457,0.0016270635],"study_design_scores_gemma":[0.000003684729,0.000012582397,0.99894863,0.000014335698,0.000030327494,0.00006814029,0.0001311676,0.00022771624,0.000024032357,0.00001715405,0.00051843,0.0000039269657],"about_ca_topic_score_codex":0.07832434,"about_ca_topic_score_gemma":0.08034389,"teacher_disagreement_score":0.07832434,"about_ca_system_score_codex":0.0017181352,"about_ca_system_score_gemma":0.0024657405,"threshold_uncertainty_score":0.15573692},"labels":[],"label_agreement":null},{"id":"W4300688804","doi":"10.1177/17562848221127238","title":"A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel disease","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seven Oaks General Hospital; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; University of Alberta; American College of Gastroenterology","keywords":"Medicine; Inflammatory bowel disease; Randomized controlled trial; Intervention (counseling); Disease; Reduction (mathematics); Internal medicine; Psychiatry","score_opus":0.006967669901076994,"score_gpt":0.2717162647988911,"score_spread":0.2647485948978141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300688804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94292504,0.0074823303,0.0018817375,0.0016833427,0.003189767,0.037209366,0.0011180831,0.00033239133,0.0041780015],"genre_scores_gemma":[0.93163717,0.0032453877,0.0067296266,0.0017252947,0.0011790649,0.05063397,0.00060248456,0.000024694398,0.0042225327],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970009,0.0016514668,0.0003381212,0.00049684034,0.00021437902,0.00029823702],"domain_scores_gemma":[0.9973667,0.0009664337,0.0005728757,0.00018841543,0.0001800453,0.0007256595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003215894,0.0018169398,0.0041424395,0.00097785,0.0010726838,0.0015463753,0.0014190268,0.0033304668,0.018521054],"category_scores_gemma":[0.0057530687,0.0010307536,0.0023072371,0.0007322703,0.0015787324,0.0016378406,0.0012257501,0.002892036,0.0013563004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9647785,0.016740019,0.0002249181,0.0013013117,0.0009767907,0.000027268674,0.00005211706,0.0001406129,0.00044171,0.000102641854,0.0003197094,0.014894328],"study_design_scores_gemma":[0.972939,0.025791528,0.00047215706,0.00007193862,0.00025343025,0.000007494275,0.000017027302,0.00013348597,0.00006705052,0.00006113269,0.00018024346,0.000005505165],"about_ca_topic_score_codex":0.002156564,"about_ca_topic_score_gemma":0.0033787042,"teacher_disagreement_score":0.018521054,"about_ca_system_score_codex":0.0011457616,"about_ca_system_score_gemma":0.0023751017,"threshold_uncertainty_score":0.06195903},"labels":[],"label_agreement":null},{"id":"W4302761323","doi":"10.1177/17562848221100106","title":"Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sorafenib; Hepatocellular carcinoma; Internal medicine; Nonalcoholic fatty liver disease; Hazard ratio; Gastroenterology; Proportional hazards model; Cohort; Liver cancer; Liver disease; Confidence interval; Oncology; Fatty liver; Surgery; Disease","score_opus":0.03148064591378786,"score_gpt":0.3733056229236373,"score_spread":0.34182497700984943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302761323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925476,0.00014434497,0.000063944906,0.000031197236,0.0000039256192,0.000009190349,0.00026523796,0.0000015529317,0.00022582248],"genre_scores_gemma":[0.9992066,0.000121700105,0.000055516124,0.000018044979,0.000010368647,0.000012323046,0.00050778256,0.0000028014804,0.000064973174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994198,0.00016633746,0.000055793436,0.0001559801,0.00009011283,0.00011208885],"domain_scores_gemma":[0.99766564,0.00024875847,0.0012405773,0.00029040547,0.00019014966,0.00036452318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013145662,0.00041755312,0.00044389305,0.0006972419,0.00045694096,0.00080074026,0.0003818499,0.00031001557,0.001374006],"category_scores_gemma":[0.002443575,0.00028384195,0.00086728367,0.0012059573,0.00032087808,0.00053572847,0.0007071034,0.0007502718,0.00019156368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047108048,0.00003884087,0.99793833,0.000007926602,0.00014694924,0.00008156437,0.000107327396,0.000049219903,0.00012891502,0.0000201753,0.00008444929,0.0009251525],"study_design_scores_gemma":[0.00003573076,0.00018855232,0.99865025,0.000007669423,0.00011451097,0.00031355143,0.0001955411,0.00020139664,0.000035193287,0.000026897327,0.0002229987,0.0000076212295],"about_ca_topic_score_codex":0.0040481696,"about_ca_topic_score_gemma":0.0040116212,"teacher_disagreement_score":0.0040481696,"about_ca_system_score_codex":0.0003719474,"about_ca_system_score_gemma":0.00042550414,"threshold_uncertainty_score":0.00804919},"labels":[],"label_agreement":null},{"id":"W4311280161","doi":"10.1177/17562848221136331","title":"Modified Mayo score <i>versus</i> Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE program","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Pfizer","keywords":"Tofacitinib; Ulcerative colitis; Medicine; Internal medicine; Clinical endpoint; Octave (electronics); Surgery; Randomized controlled trial; Disease; Rheumatoid arthritis","score_opus":0.045113884199184245,"score_gpt":0.3249951007128367,"score_spread":0.2798812165136525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311280161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989847,0.0027130882,0.0010705118,0.00020128426,0.000040652296,0.00034986102,0.0035741439,0.000047707996,0.0021556523],"genre_scores_gemma":[0.9951055,0.00025732908,0.00088575063,0.000118962285,0.00005376306,0.00032402223,0.0028283603,0.000016368464,0.00040993994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925408,0.0047466103,0.0006099108,0.0006120054,0.0012913697,0.00019940302],"domain_scores_gemma":[0.98650813,0.0062540295,0.004384622,0.0011074046,0.0008289285,0.0009168676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011112965,0.00055641145,0.0017798999,0.00069963944,0.0002116683,0.00069225236,0.0004914707,0.00055988965,0.0015949575],"category_scores_gemma":[0.009276511,0.00018977115,0.0017229837,0.0006729471,0.000241681,0.0006883384,0.0004935316,0.00089285284,0.00023108105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4083837,0.0025839852,0.5044184,0.00079787464,0.012258593,0.0001076816,0.00019953297,0.001772163,0.0060537294,0.00014912915,0.003186336,0.06008885],"study_design_scores_gemma":[0.01751966,0.044462867,0.92693114,0.00009143434,0.003088755,0.00029213098,0.00006420197,0.003041644,0.0018914017,0.00012362363,0.002441701,0.000051575633],"about_ca_topic_score_codex":0.0004212407,"about_ca_topic_score_gemma":0.0010401525,"teacher_disagreement_score":0.011112965,"about_ca_system_score_codex":0.00027833384,"about_ca_system_score_gemma":0.00038378648,"threshold_uncertainty_score":0.05877167},"labels":[],"label_agreement":null},{"id":"W4323967376","doi":"10.1177/17562848231158235","title":"Update on the role of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitis","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Ulcerative colitis; Adverse effect; Inflammatory bowel disease; Clinical trial; Placebo; Colitis; Drug; Janus kinase; Tofacitinib; Pharmacology; Internal medicine; Disease; Pathology; Cytokine","score_opus":0.019733564709320157,"score_gpt":0.3067597717585201,"score_spread":0.28702620704919996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323967376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010809871,0.9969317,0.00008251,0.0006790007,0.0009040905,0.000007389877,0.000050240953,0.0000117032205,0.0012252828],"genre_scores_gemma":[0.0004877548,0.9968829,0.00017692418,0.0008972959,0.0006135941,0.000009468475,0.00008450225,0.000002670604,0.00084488996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997795,0.0000458933,0.000040334762,0.000024997176,0.00008955608,0.000019763742],"domain_scores_gemma":[0.9994716,0.0002459268,0.000080853715,0.000009564087,0.0001425513,0.000049468174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007166721,0.0006477593,0.0011850101,0.0017555368,0.00022398008,0.0009058081,0.00095445063,0.0010901889,0.005362365],"category_scores_gemma":[0.0011310785,0.00022274467,0.0008040112,0.0014892742,0.0002539866,0.0010364994,0.0005236319,0.0024343068,0.0024342951],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015292226,0.000055282144,0.000101669044,0.018702243,0.00014506529,0.0002338476,0.00004656826,0.00024094076,0.00085965515,0.001674393,0.11114792,0.86663944],"study_design_scores_gemma":[0.000040564024,0.00010036054,0.0005291871,0.0047832285,0.00022074046,0.0007603865,0.000025215448,0.000054122283,0.00012706705,0.00059840723,0.9927489,0.000011784208],"about_ca_topic_score_codex":0.0010691447,"about_ca_topic_score_gemma":0.002800095,"teacher_disagreement_score":0.005362365,"about_ca_system_score_codex":0.00052696856,"about_ca_system_score_gemma":0.00095539546,"threshold_uncertainty_score":0.017938912},"labels":[],"label_agreement":null},{"id":"W4362684655","doi":"10.1177/17562848231159452","title":"Is there an optimal sequence of biologic therapies for inflammatory bowel disease?","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Inflammatory bowel disease; Sequence (biology); Disease; Intensive care medicine; Bioinformatics; Internal medicine","score_opus":0.046848822251988095,"score_gpt":0.35779434098470464,"score_spread":0.31094551873271653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362684655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010298437,0.84271485,0.011696136,0.115111545,0.008535799,0.0007034228,0.0005271147,0.0001747898,0.010237901],"genre_scores_gemma":[0.093103625,0.6621465,0.082112946,0.14202546,0.012018468,0.0029675511,0.0008733113,0.00029160207,0.004460491],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99252534,0.0037514295,0.0014610317,0.00075308164,0.0012808433,0.00022829788],"domain_scores_gemma":[0.9840019,0.011251673,0.0020286618,0.00060510676,0.0013488089,0.00076385465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012244435,0.00064501853,0.0037075575,0.0007862355,0.000690707,0.003552845,0.0014461778,0.0026891667,0.008031542],"category_scores_gemma":[0.02804326,0.00059374917,0.0024909368,0.00078883546,0.0014612713,0.006204475,0.0011763979,0.006269296,0.0025672538],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067771683,0.0009963264,0.0023498624,0.035419036,0.001654662,0.00022127393,0.00041989074,0.001156379,0.0012293882,0.0229319,0.030967625,0.8958764],"study_design_scores_gemma":[0.011276533,0.010229731,0.006327652,0.13564324,0.0050257896,0.0014686164,0.0019568456,0.0016424478,0.0019198315,0.13042334,0.6937826,0.0003034887],"about_ca_topic_score_codex":0.00091910653,"about_ca_topic_score_gemma":0.002478544,"teacher_disagreement_score":0.012244435,"about_ca_system_score_codex":0.0015502217,"about_ca_system_score_gemma":0.0053532124,"threshold_uncertainty_score":0.0647555},"labels":[],"label_agreement":null},{"id":"W4367021126","doi":"10.1177/17562848231167953","title":"IBD barriers across the continents: a continent-specific analysis: Latin America","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Calgary; Lunenfeld-Tanenbaum Research Institute","funders":"Pfizer","keywords":"Latin Americans; Medicine; Epidemiology; Health care; Healthcare system; Family medicine; Economic growth; Pathology; Political science","score_opus":0.02112578555837125,"score_gpt":0.33316709551729035,"score_spread":0.3120413099589191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367021126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006581989,0.98969483,0.00012293771,0.001113527,0.00011685934,0.000041501193,0.00033824303,0.0000070143287,0.001982966],"genre_scores_gemma":[0.039790154,0.958291,0.00040116056,0.00060298457,0.00010372064,0.00006203527,0.0004308081,0.000005833143,0.00031240942],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928504,0.0002609316,0.00015218699,0.000089679255,0.00012564837,0.00008643258],"domain_scores_gemma":[0.99866676,0.0007413484,0.00028904653,0.000028459279,0.0002077394,0.000066625595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017012578,0.0004900717,0.0014186815,0.0025053276,0.0004202029,0.0014645215,0.000552283,0.000661369,0.0036655278],"category_scores_gemma":[0.0033335816,0.00019832712,0.0018561602,0.004833429,0.00035802086,0.0011669697,0.0008570812,0.0006657131,0.00024756475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005505897,0.00010053669,0.038348194,0.1796056,0.0038627894,0.0011986956,0.0030546007,0.0004537066,0.00079461513,0.004381476,0.014168341,0.75348085],"study_design_scores_gemma":[0.00018842732,0.00045165708,0.17666285,0.20615797,0.013242027,0.005984985,0.008315889,0.0003538225,0.00060814933,0.002599557,0.5853284,0.000106268606],"about_ca_topic_score_codex":0.008892818,"about_ca_topic_score_gemma":0.013869968,"teacher_disagreement_score":0.008892818,"about_ca_system_score_codex":0.000973944,"about_ca_system_score_gemma":0.0036487198,"threshold_uncertainty_score":0.017682076},"labels":[],"label_agreement":null},{"id":"W4367278801","doi":"10.1177/17562848231166227","title":"Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Vedolizumab; Internal medicine; Cochrane Library; Ulcerative colitis; Placebo; Context (archaeology); Adverse effect; Randomized controlled trial; Meta-analysis; Inflammatory bowel disease; Crohn's disease; Cohort; Gastroenterology; Surgery; Disease; Pathology; Alternative medicine","score_opus":0.027555044110784205,"score_gpt":0.31802472313096497,"score_spread":0.2904696790201808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367278801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037625562,0.9948214,0.00039887056,0.00014473611,0.00009394449,0.0003352078,0.0002784965,0.000015727768,0.00014897209],"genre_scores_gemma":[0.12374305,0.87055963,0.0023323335,0.0006405768,0.00019795321,0.0016065422,0.00066929683,0.000020440246,0.0002303059],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9906957,0.0041917996,0.00289347,0.00081402756,0.0011164708,0.00028846654],"domain_scores_gemma":[0.98558205,0.009585285,0.0028974118,0.00040201517,0.0012626243,0.00027060407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0130938785,0.002698715,0.021662537,0.008765994,0.00065569754,0.0030035018,0.0023815199,0.0021755737,0.003123013],"category_scores_gemma":[0.025818761,0.0015309134,0.03940532,0.008918188,0.0007021048,0.001940699,0.0015791871,0.00164868,0.00023555543],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020495045,0.000047048754,0.0029472068,0.4315807,0.5501077,0.00011522653,0.00008833537,0.00047156136,0.00017761045,0.00011366688,0.00045134444,0.011850058],"study_design_scores_gemma":[0.0006149186,0.00022703774,0.0026368895,0.025248706,0.9695957,0.00008141913,0.000048653295,0.00019703252,0.00008130065,0.00012108264,0.0011252476,0.000022055288],"about_ca_topic_score_codex":0.006446878,"about_ca_topic_score_gemma":0.01398183,"teacher_disagreement_score":0.021662537,"about_ca_system_score_codex":0.003071974,"about_ca_system_score_gemma":0.004249572,"threshold_uncertainty_score":0.06924784},"labels":[],"label_agreement":null},{"id":"W4378901451","doi":"10.1177/17562848231171756","title":"A review of the role of intermittent fasting in the management of inflammatory bowel disease","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Dietary Effects on Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Ulcerative colitis; Disease; Observational study; Randomized controlled trial; Intermittent fasting; Crohn's disease; Weight loss; Colitis; Internal medicine; Clinical trial; Gastroenterology; Weight management; Microbiome; Animal studies; Bioinformatics; Obesity","score_opus":0.03118164510584033,"score_gpt":0.3663004977127716,"score_spread":0.3351188526069313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378901451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058966823,0.9995103,0.00002871022,0.000076509124,0.000094315925,0.000007820873,0.000020722984,0.0000022168542,0.00020037965],"genre_scores_gemma":[0.0003487689,0.99929845,0.00009332854,0.000095252544,0.000051631632,0.000010126067,0.000021240201,6.309838e-7,0.00008052562],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99931824,0.00017856511,0.00022376544,0.00007513338,0.00016682077,0.000037620597],"domain_scores_gemma":[0.9983846,0.0010809243,0.00026880082,0.000021567046,0.00019724453,0.000046879675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001213589,0.0010690372,0.0023788852,0.004975712,0.00035193685,0.0012782252,0.0010367181,0.0010520777,0.005059437],"category_scores_gemma":[0.0033049376,0.00036988113,0.001580748,0.005710002,0.00035880812,0.0012384286,0.0006629805,0.0010668875,0.00084824284],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016802971,0.000047752605,0.00017125804,0.48077482,0.0007245415,0.00020598203,0.00018716096,0.00026693245,0.0006844614,0.0013417612,0.021776749,0.4936505],"study_design_scores_gemma":[0.000091059694,0.00029762572,0.0026439263,0.3109483,0.0042372043,0.001906473,0.00022015118,0.00012884963,0.00034500632,0.0014530921,0.67768,0.000048272188],"about_ca_topic_score_codex":0.0023166223,"about_ca_topic_score_gemma":0.0048947637,"teacher_disagreement_score":0.005059437,"about_ca_system_score_codex":0.000880511,"about_ca_system_score_gemma":0.0024954372,"threshold_uncertainty_score":0.016925573},"labels":[],"label_agreement":null},{"id":"W4380371766","doi":"10.1177/17562848231174277","title":"Safety of fecal microbiota, live-jslm (REBYOTA<sup>™</sup>) in individuals with recurrent <i>Clostridioides difficile</i> infection: data from five prospective clinical trials","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of British Columbia; University of Calgary; University of Victoria; Island Health","funders":"Ferring","keywords":"Medicine; Placebo; Adverse effect; Clinical trial; Nausea; Internal medicine; Regimen","score_opus":0.08476244952894932,"score_gpt":0.40750689638980137,"score_spread":0.322744446860852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380371766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9158538,0.06967685,0.0018519933,0.0009753075,0.00020188875,0.0021808727,0.0036971276,0.000108294764,0.005453934],"genre_scores_gemma":[0.98554844,0.009360342,0.0012736688,0.0006406541,0.00010761456,0.00081699056,0.0016278592,0.000014492763,0.0006098278],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9966627,0.0016956445,0.0007186722,0.00041496567,0.00039282427,0.000115237846],"domain_scores_gemma":[0.9909094,0.0034477783,0.0038493297,0.0005105294,0.0008075669,0.00047530493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006270158,0.00041684264,0.00093689444,0.000353994,0.00032368663,0.0010931403,0.00043921216,0.00087438227,0.0035766435],"category_scores_gemma":[0.0063259564,0.00021313716,0.0016604989,0.0006233378,0.00062191545,0.00066365936,0.00027385086,0.0009123529,0.00046458156],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58243805,0.0060875826,0.058250368,0.018696487,0.017207982,0.00017763938,0.00033591434,0.0013734634,0.01658891,0.0005384372,0.0051654126,0.29313982],"study_design_scores_gemma":[0.30365032,0.48298138,0.14203069,0.0039278185,0.02439688,0.0012891132,0.00037104072,0.0014166627,0.017982883,0.00083895674,0.020993011,0.00012126525],"about_ca_topic_score_codex":0.00025344643,"about_ca_topic_score_gemma":0.00083075993,"teacher_disagreement_score":0.006270158,"about_ca_system_score_codex":0.0004219486,"about_ca_system_score_gemma":0.0009694873,"threshold_uncertainty_score":0.03316015},"labels":[],"label_agreement":null},{"id":"W4386310961","doi":"10.1177/17562848231194395","title":"Handgrip strength and risk of malnutrition are associated with an increased risk of hospitalizations in inflammatory bowel disease patients","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Inflammatory bowel disease; Malnutrition; Disease; Sarcopenia; Internal medicine","score_opus":0.009753165208807781,"score_gpt":0.27809093972146093,"score_spread":0.26833777451265317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386310961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993197,0.00029060658,0.000029761319,0.00004842584,0.0000046667087,0.0000026892149,0.00008918164,0.0000024592107,0.00021263017],"genre_scores_gemma":[0.99969816,0.00007176265,0.000029544506,0.000013273757,0.0000065200243,0.0000016381813,0.00011719877,6.30311e-7,0.00006123574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997104,0.000065740336,0.000026825206,0.000043280783,0.00007539446,0.00007835957],"domain_scores_gemma":[0.9982204,0.00020095415,0.00092008733,0.000069463,0.00016843142,0.00042069345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034428737,0.0002941562,0.00028642232,0.0004685176,0.0004055703,0.00051516626,0.00030300693,0.00038403575,0.0018030093],"category_scores_gemma":[0.0019275169,0.00021609031,0.00037752272,0.0006925559,0.00028116367,0.00022863438,0.00035259422,0.0007343671,0.00016319963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049309972,0.0000069183625,0.9994766,0.0000024831797,0.000014732523,0.000020963234,0.000009648767,0.000012470415,0.0000335553,0.0000021255266,0.00002772623,0.0003434392],"study_design_scores_gemma":[0.0000019046369,0.000022732509,0.99974424,0.0000026864886,0.000009173917,0.00008138441,0.000027714801,0.00006741853,0.0000075508515,0.000004101722,0.000029952673,0.0000011173113],"about_ca_topic_score_codex":0.015146219,"about_ca_topic_score_gemma":0.018973628,"teacher_disagreement_score":0.015146219,"about_ca_system_score_codex":0.00040415808,"about_ca_system_score_gemma":0.0005745337,"threshold_uncertainty_score":0.03011614},"labels":[],"label_agreement":null},{"id":"W4391826282","doi":"10.1177/17562848231222344","title":"Economic impact of inflammatory bowel disease in Catalonia: a population-based analysis","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Health care; Population; Per capita; Ulcerative colitis; Observational study; Crohn's disease; Disease; Environmental health; Internal medicine","score_opus":0.004106138242822802,"score_gpt":0.27484723528338517,"score_spread":0.2707410970405624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391826282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927549,0.0023922753,0.00012611636,0.00012610528,0.000021045647,0.000035417816,0.0040277434,0.000005790242,0.0005106682],"genre_scores_gemma":[0.9939003,0.0010785613,0.00016276246,0.000057061927,0.00002702802,0.00004085623,0.0045743743,0.000004091337,0.00015502477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984516,0.00064700725,0.00021460622,0.00025538256,0.00021625185,0.00021512505],"domain_scores_gemma":[0.9970591,0.00077988143,0.001190506,0.00020852337,0.0003978021,0.00036416645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025596155,0.00063278305,0.00078040693,0.0032714382,0.0003639719,0.0016632456,0.0008662607,0.0007370727,0.0021284514],"category_scores_gemma":[0.0031166924,0.00037723206,0.0020037575,0.003324132,0.0003535872,0.0003493728,0.0010366772,0.0007104472,0.00025638455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031631475,0.000048931153,0.9954958,0.000114104536,0.0006682107,0.00018495611,0.000063473075,0.000874105,0.000039721228,0.000042871994,0.0005763842,0.0015750637],"study_design_scores_gemma":[0.000025533633,0.000066416236,0.9981487,0.000042605094,0.0001555457,0.00013979654,0.00023407787,0.0007577706,0.000006138911,0.000024552459,0.00039061654,0.00000832632],"about_ca_topic_score_codex":0.057547122,"about_ca_topic_score_gemma":0.031758483,"teacher_disagreement_score":0.057547122,"about_ca_system_score_codex":0.0026770793,"about_ca_system_score_gemma":0.0011433575,"threshold_uncertainty_score":0.11442435},"labels":[],"label_agreement":null},{"id":"W4392250424","doi":"10.1177/17562848241230904","title":"Stricture dilation <i>via</i> balloon-assisted endoscopy in Crohn’s disease: approach and intraprocedural outcomes with the single-balloon and double-balloon systems","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; St. Michael's Hospital; University of Alberta","funders":"University of Alberta","keywords":"Medicine; Balloon dilation; Retrospective cohort study; Endoscopy; Balloon; Endoscope; Surgery; Crohn's disease; Cohort; Radiology; Internal medicine; Disease","score_opus":0.016515849969582934,"score_gpt":0.2668439261640955,"score_spread":0.2503280761945126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392250424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988607,0.0007855455,0.0000604564,0.000015388876,0.000002724922,0.0000068273066,0.000027554117,0.0000018417799,0.00023892484],"genre_scores_gemma":[0.9994697,0.00029380133,0.00009334614,0.000016350034,0.000011566279,0.0000045712004,0.000071924165,0.0000012543677,0.000037546437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994716,0.00012029993,0.000093719704,0.00008921297,0.00015338234,0.00007183102],"domain_scores_gemma":[0.9970601,0.0006500085,0.0016205928,0.0001542628,0.00020194847,0.00031303364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011872296,0.00014398803,0.00033468867,0.0006262273,0.0002783893,0.0006685542,0.00019412262,0.00029802296,0.000562128],"category_scores_gemma":[0.0030173683,0.00013419679,0.0004196009,0.00047104456,0.00035492732,0.00049837126,0.0004025683,0.00030291305,0.00013176352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000506499,0.000055678345,0.99203086,0.000034580706,0.000055017816,0.0002134526,0.00006127972,0.00003837509,0.00046217244,0.000012861279,0.000035107856,0.006494168],"study_design_scores_gemma":[0.000020259567,0.0015088996,0.9951315,0.000029428595,0.00006787331,0.002408124,0.00014514272,0.00017331283,0.00030538932,0.000019694553,0.00018415971,0.000006257779],"about_ca_topic_score_codex":0.0005754464,"about_ca_topic_score_gemma":0.0014103048,"teacher_disagreement_score":0.0011872296,"about_ca_system_score_codex":0.00040690284,"about_ca_system_score_gemma":0.0002776781,"threshold_uncertainty_score":0.0062787533},"labels":[],"label_agreement":null},{"id":"W4393090998","doi":"10.1177/17562848241239606","title":"Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"Szent-Györgyi Albert Orvostudományi Kar, Szegedi Tudományegyetem; Szegedi Tudományegyetem; National Research, Development and Innovation Office; Emberi Eroforrások Minisztériuma","keywords":"Medicine; Ulcerative colitis; Colonoscopy; Internal medicine; Colectomy; Disease; Severity of illness; Retrospective cohort study; Colorectal cancer; Cancer","score_opus":0.01622745357558949,"score_gpt":0.293779502362303,"score_spread":0.2775520487867135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836331,0.006050046,0.0045197215,0.00054086966,0.00011210024,0.00009120137,0.001564084,0.00007597215,0.003412859],"genre_scores_gemma":[0.99646395,0.0005876174,0.0018602365,0.000047292207,0.00009765671,0.000027623024,0.0007256217,0.000006486176,0.0001835422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983175,0.00061978685,0.0001992675,0.00025180264,0.0005124186,0.00009931571],"domain_scores_gemma":[0.9940183,0.0018113597,0.0021661704,0.00031843848,0.0012179958,0.00046769273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046142763,0.0008433364,0.00071050174,0.0020779537,0.0002611485,0.0010629765,0.0005185473,0.0005699024,0.00076502835],"category_scores_gemma":[0.009046325,0.00020256218,0.0007166011,0.00089453685,0.00034957973,0.0008643204,0.0006061439,0.0005877502,0.00039846048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042040006,0.00004454907,0.9811669,0.000051745883,0.00022847405,0.000033158605,0.000019254798,0.00045766728,0.00032934008,0.000039063267,0.0003954211,0.016814006],"study_design_scores_gemma":[0.00006228514,0.0008507688,0.9890047,0.000080053,0.00025965658,0.00052297435,0.000059409205,0.007751367,0.00034175903,0.00021340829,0.0008276695,0.000026103717],"about_ca_topic_score_codex":0.0013459206,"about_ca_topic_score_gemma":0.002442901,"teacher_disagreement_score":0.0046142763,"about_ca_system_score_codex":0.00031916556,"about_ca_system_score_gemma":0.0004359255,"threshold_uncertainty_score":0.024402916},"labels":[],"label_agreement":null},{"id":"W4399046147","doi":"10.1177/17562848241254267","title":"Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Fondo Nacional de Desarrollo Científico y Tecnológico","keywords":"Medicine; Rifaximin; Internal medicine; Hepatic encephalopathy; Cirrhosis; Spontaneous bacterial peritonitis; Cohort; Liver disease; Gastroenterology; Model for End-Stage Liver Disease; Pneumonia; Mortality rate; Antibiotics; Liver transplantation","score_opus":0.010454501987918665,"score_gpt":0.29505882608773126,"score_spread":0.2846043240998126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399046147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988458,0.00072349166,0.00003755629,0.000068885885,0.000008413302,0.0000037911304,0.00011250733,0.000001525187,0.00019798845],"genre_scores_gemma":[0.99970204,0.000112232825,0.000022756643,0.000014631005,0.00001200319,0.0000024931687,0.00009810486,5.543315e-7,0.000035131812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993461,0.00023796779,0.00007938522,0.00009622445,0.000099701174,0.00014068757],"domain_scores_gemma":[0.9971578,0.0005441171,0.0016873879,0.000101096324,0.000113082446,0.0003965653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087147567,0.00024255663,0.00033962962,0.00045916735,0.00033828794,0.0005277467,0.0002419879,0.00032199937,0.0013953628],"category_scores_gemma":[0.0031324986,0.0002063971,0.0006649706,0.0006983931,0.00021113957,0.0003648477,0.00042265147,0.0005083379,0.00013744897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026335026,0.000022409977,0.9987056,0.000008704623,0.000047804617,0.000059590115,0.000011491012,0.000030690102,0.000029935487,0.0000063645825,0.00003131192,0.0007826368],"study_design_scores_gemma":[0.000015691734,0.00019270586,0.9989826,0.000013814126,0.00004691988,0.00028797553,0.00006340551,0.00026272182,0.000029071183,0.000018277895,0.00008370358,0.000003130763],"about_ca_topic_score_codex":0.0014002862,"about_ca_topic_score_gemma":0.0018498219,"teacher_disagreement_score":0.0014002862,"about_ca_system_score_codex":0.00037250592,"about_ca_system_score_gemma":0.00046948282,"threshold_uncertainty_score":0.0046679974},"labels":[],"label_agreement":null},{"id":"W4401433256","doi":"10.1177/17562848241265776","title":"Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Adalimumab; Medicine; Inflammatory bowel disease; Tolerability; Internal medicine; Crohn's disease; Disease; Gastroenterology; Adverse effect","score_opus":0.008517368546243338,"score_gpt":0.2671136693772876,"score_spread":0.25859630083104423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401433256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999511,0.00007095228,0.000024491892,0.000038012407,0.0000014734708,0.000011182268,0.00012057965,6.6823566e-7,0.00022160128],"genre_scores_gemma":[0.9995648,0.000076394965,0.000034332126,0.00006816627,0.0000037699185,0.0000129425025,0.00016079862,0.0000011145409,0.00007761822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988738,0.0004499898,0.00011241417,0.000115552,0.00028239124,0.00016587345],"domain_scores_gemma":[0.99783,0.00037562184,0.0010595613,0.000109968525,0.00024253427,0.0003822443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012464931,0.0001462217,0.00032484037,0.00054253056,0.0005160713,0.00064905797,0.00023070966,0.00052809494,0.0022256104],"category_scores_gemma":[0.0027360166,0.00029691207,0.00062936737,0.001291465,0.00037568706,0.0005741111,0.0007267797,0.0005359077,0.00031080333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011017566,0.00007662479,0.9976494,0.000016739925,0.00003934178,0.00005094094,0.00049639936,0.000007807294,0.0001261788,0.000006194187,0.00009313189,0.0013271456],"study_design_scores_gemma":[0.000008715784,0.00012208043,0.9989911,0.0000044027674,0.00001206521,0.0000998069,0.00060493994,0.000036369107,0.000011364013,0.0000023723305,0.00010447361,0.000002339278],"about_ca_topic_score_codex":0.00842378,"about_ca_topic_score_gemma":0.009140853,"teacher_disagreement_score":0.00842378,"about_ca_system_score_codex":0.00044263242,"about_ca_system_score_gemma":0.00037169608,"threshold_uncertainty_score":0.016749501},"labels":[],"label_agreement":null},{"id":"W4403447964","doi":"10.1177/17562848241290346","title":"A retrospective real-world study on the safety and efficacy of budesonide orodispersible tablets for the induction therapy of eosinophilic oesophagitis","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Eosinophilic esophagitis; Budesonide; Gastroenterology; Induction therapy; Internal medicine; Retrospective cohort study; Corticosteroid; Disease","score_opus":0.026085919811959308,"score_gpt":0.3290994750372087,"score_spread":0.3030135552252494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403447964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742484,0.0009565319,0.00024466112,0.00004798103,0.000016594187,0.00032888108,0.0005484957,0.0000043808654,0.00042753445],"genre_scores_gemma":[0.99808323,0.00025688283,0.0003112201,0.00014585968,0.000044843546,0.00023412034,0.0007363812,0.0000041325898,0.00018331646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578226,0.0016941287,0.00061437144,0.00099566,0.0006649138,0.00024862745],"domain_scores_gemma":[0.9818247,0.004723082,0.008821177,0.002058752,0.0012942167,0.001278023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005251545,0.0004436344,0.0010363247,0.0006566697,0.00065375044,0.0009787813,0.00043520637,0.0007853388,0.0022408627],"category_scores_gemma":[0.011671335,0.0005239065,0.00077758793,0.0008030032,0.0007361984,0.00068235816,0.0005120236,0.0007745558,0.00047363847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015549427,0.0014399004,0.9714289,0.0004079,0.0007533438,0.001179492,0.0008060323,0.000109619905,0.0011520797,0.000083192186,0.00053045637,0.006559712],"study_design_scores_gemma":[0.0019956823,0.028498553,0.96153694,0.00011823923,0.0007836022,0.0029481994,0.0006720106,0.00035975795,0.00043825296,0.000048120943,0.0025400384,0.00006062116],"about_ca_topic_score_codex":0.0013080904,"about_ca_topic_score_gemma":0.0012235956,"teacher_disagreement_score":0.005251545,"about_ca_system_score_codex":0.0006449266,"about_ca_system_score_gemma":0.00090690056,"threshold_uncertainty_score":0.027773142},"labels":[],"label_agreement":null},{"id":"W4403455365","doi":"10.1177/17562848241290636","title":"Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"Szent-Györgyi Albert Orvostudományi Kar, Szegedi Tudományegyetem; National Research, Development and Innovation Office; Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; Bristol-Myers Squibb; Eli Lilly and Company; Szegedi Tudományegyetem; Emberi Eroforrások Minisztériuma; Celltrion; Teva Pharmaceutical Industries; Gilead Sciences; Amgen; Pfizer; Horizon 2020 Framework Programme","keywords":"Vedolizumab; Medicine; Inflammatory bowel disease; Internal medicine; Gastroenterology; Disease","score_opus":0.005912891383417481,"score_gpt":0.2692807805838435,"score_spread":0.26336788920042603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403455365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991755,0.0004428791,0.000034635883,0.00002243532,0.0000039899373,0.000018969902,0.0000853888,0.0000015448146,0.00021459474],"genre_scores_gemma":[0.99949455,0.00010921714,0.00003175016,0.000021568221,0.000009983469,0.00001576647,0.00022885222,8.412228e-7,0.00008750153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986739,0.0004912329,0.00017639603,0.00016435474,0.00029533342,0.0001987032],"domain_scores_gemma":[0.9916401,0.001617139,0.005236461,0.00024563604,0.00046113625,0.0007995396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025014896,0.00025353127,0.00061651604,0.0005393804,0.0003759067,0.000626863,0.00027051294,0.0005008333,0.0011815734],"category_scores_gemma":[0.0057572816,0.00013147159,0.0011525446,0.00056532066,0.0002405158,0.0005181652,0.00047911357,0.0007324332,0.00014927766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074689295,0.00055525044,0.97542906,0.000091828224,0.00029573307,0.00017736973,0.00018132778,0.00017345969,0.00046839745,0.000013148024,0.00009642082,0.01504914],"study_design_scores_gemma":[0.00010286408,0.0029030049,0.99597436,0.000014388215,0.00013803739,0.00020987034,0.0000917306,0.0002342633,0.0001560859,0.0000124130975,0.00015460176,0.000008288201],"about_ca_topic_score_codex":0.00081133307,"about_ca_topic_score_gemma":0.0007568907,"teacher_disagreement_score":0.0025014896,"about_ca_system_score_codex":0.0004425394,"about_ca_system_score_gemma":0.00027648403,"threshold_uncertainty_score":0.0132293105},"labels":[],"label_agreement":null},{"id":"W4403778739","doi":"10.1177/17562848241272995","title":"Advanced combination therapy: is it the best way to break the therapeutic ceiling?","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Ulcerative colitis; Therapeutic approach; Disease; Refractory (planetary science); Vedolizumab; Inflammatory bowel disease; Intensive care medicine; Therapeutic effect; Clinical trial; Biologic Agents; Internal medicine","score_opus":0.024422860439279014,"score_gpt":0.3410506527082592,"score_spread":0.3166277922689802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403778739","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011206859,0.9985752,0.00011753012,0.00051633053,0.00018208109,0.000004557733,0.000008564294,0.0000051719912,0.00047848615],"genre_scores_gemma":[0.0007309731,0.99816006,0.00023809669,0.00037643765,0.00016164756,0.000008828085,0.000018545245,0.0000016163968,0.0003037837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997384,0.000077937395,0.000036665617,0.000041607775,0.000075772565,0.00002953682],"domain_scores_gemma":[0.9996911,0.00017890621,0.000038753595,0.000009829629,0.000058026813,0.000023419165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076737645,0.00072350795,0.0017932694,0.0011366323,0.00025231854,0.0012614394,0.0009993832,0.0012390498,0.0032445814],"category_scores_gemma":[0.0007791707,0.00022485801,0.00073104276,0.0010487845,0.0005769611,0.0016566339,0.0005496693,0.0028727779,0.0014581931],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016896485,0.000087761444,0.00012317098,0.019144675,0.0001612949,0.00019318929,0.00006442748,0.0003267661,0.0016194079,0.0044604023,0.021270841,0.95237917],"study_design_scores_gemma":[0.00008244565,0.00031385777,0.00065261475,0.0073149605,0.00023728197,0.001658505,0.00010243496,0.00013871535,0.00056571385,0.0037199748,0.98518836,0.000025182324],"about_ca_topic_score_codex":0.00053919666,"about_ca_topic_score_gemma":0.0013941434,"teacher_disagreement_score":0.0032445814,"about_ca_system_score_codex":0.00058584334,"about_ca_system_score_gemma":0.00082644547,"threshold_uncertainty_score":0.010854185},"labels":[],"label_agreement":null},{"id":"W4404194478","doi":"10.1177/17562848241293643","title":"Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: an analysis of the phase II OASIS and phase III ELEVATE UC 52 and ELEVATE UC 12 clinical trials","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; UCB Pharma; Sun Pharma; Astellas Pharma; Celltrion; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Celltrion Healthcare; Gilead Sciences; GlaxoSmithKline; Tillotts Pharma; Amgen; Dr. Falk Pharma; Pfizer; Celgene","keywords":"Medicine; Ulcerative colitis; Adverse effect; Phases of clinical research; Phase (matter); Internal medicine; Clinical trial; Gastroenterology; Intensive care medicine; Disease","score_opus":0.01593308882847572,"score_gpt":0.35102174349784043,"score_spread":0.3350886546693647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404194478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845185,0.011506866,0.0006615592,0.00016579694,0.00006201195,0.00082516123,0.001373067,0.000021503067,0.0008655598],"genre_scores_gemma":[0.99506986,0.0018669064,0.0004920562,0.0002260598,0.00010805397,0.00047718792,0.00150161,0.000010244339,0.0002480419],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99162334,0.0054139188,0.001024089,0.0006603515,0.0010243157,0.0002540449],"domain_scores_gemma":[0.9820187,0.010289008,0.0053654294,0.0007442972,0.00065715454,0.0009253614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013919595,0.0006391067,0.0021995227,0.00064018246,0.0002812205,0.0009522276,0.00041013633,0.000668645,0.0012298193],"category_scores_gemma":[0.009495134,0.0002992746,0.0046435646,0.0009179342,0.00042238043,0.00062602677,0.00043889784,0.0011445158,0.00011446504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60186857,0.0020701133,0.2960828,0.0033967162,0.03715604,0.00035748753,0.00018154706,0.0020962674,0.0055641094,0.00017325587,0.0018567261,0.04919633],"study_design_scores_gemma":[0.11180473,0.10206558,0.753089,0.00029339464,0.021792665,0.000984498,0.00018599814,0.003527888,0.0015448793,0.0003153909,0.004291771,0.0001041339],"about_ca_topic_score_codex":0.000201733,"about_ca_topic_score_gemma":0.0006329495,"teacher_disagreement_score":0.013919595,"about_ca_system_score_codex":0.0004227468,"about_ca_system_score_gemma":0.0006578505,"threshold_uncertainty_score":0.07361472},"labels":[],"label_agreement":null},{"id":"W4404431078","doi":"10.1177/17562848241276334","title":"Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Fondo Nacional de Desarrollo Científico y Tecnológico","keywords":"Medicine; Liver biopsy; Biopsy; Gold standard (test); Radiology; Modalities; Liver disease; Review article; Disease; Intensive care medicine; Pathology; Internal medicine","score_opus":0.032745013237926876,"score_gpt":0.33499491708931933,"score_spread":0.30224990385139244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404431078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013472744,0.9982273,0.00023619755,0.00045448123,0.00018003455,0.0000041350945,0.00001697312,0.000009338987,0.00073674455],"genre_scores_gemma":[0.0006809752,0.99804026,0.00046916518,0.0002977197,0.00022343367,0.000004724144,0.000031160864,0.0000023263467,0.00025024454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996123,0.00008890666,0.000060289927,0.00006220973,0.00014791536,0.000028405842],"domain_scores_gemma":[0.99906474,0.0005163096,0.00010036254,0.000025749041,0.00024938496,0.000043392643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010643405,0.0007163191,0.0012372383,0.0030577616,0.00023495183,0.0012055138,0.00063635793,0.001041135,0.0029311364],"category_scores_gemma":[0.0014719807,0.0002197201,0.0007578387,0.0022722334,0.0005880598,0.0018218637,0.0006793905,0.0019141274,0.0013786015],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006626093,0.000058977213,0.00055145065,0.025433991,0.000146247,0.0002276648,0.00008342254,0.00027955914,0.0019109793,0.0034849362,0.01995649,0.9478001],"study_design_scores_gemma":[0.000016761856,0.00013397848,0.0022622035,0.010104978,0.00026057204,0.0026071856,0.00012914182,0.00018203442,0.000920257,0.0031843989,0.98016465,0.000033871253],"about_ca_topic_score_codex":0.0011267891,"about_ca_topic_score_gemma":0.0021665588,"teacher_disagreement_score":0.0030577616,"about_ca_system_score_codex":0.00063758093,"about_ca_system_score_gemma":0.0013615219,"threshold_uncertainty_score":0.009805679},"labels":[],"label_agreement":null},{"id":"W4404555515","doi":"10.1177/17562848241299739","title":"Bowel preparation efficacy and discomfort of 2 L polyethylene glycol combined with linaclotide versus 3 L polyethylene glycol: a noninferiority, prospective, multicenter, randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regimen; Randomized controlled trial; Tolerability; Colonoscopy; PEG ratio; Internal medicine; Gastroenterology; Bloating; Polyethylene glycol; Surgery; Adverse effect; Nausea; Colorectal cancer; Chemistry","score_opus":0.009608364835663408,"score_gpt":0.31178746396981133,"score_spread":0.3021790991341479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404555515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892916,0.0055452506,0.0006349142,0.00040102907,0.00043544394,0.0027189734,0.000341403,0.000050929113,0.0005805014],"genre_scores_gemma":[0.98911613,0.0022561296,0.0018328904,0.00071647216,0.00061869086,0.0043352363,0.00036352075,0.000014418608,0.0007464684],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972445,0.0017646613,0.00022789605,0.00035847301,0.00022045596,0.00018408615],"domain_scores_gemma":[0.99658966,0.0011624935,0.0012422838,0.00024417968,0.000195995,0.0005653671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003924497,0.0016835019,0.004321642,0.00054638425,0.00052621093,0.0012766911,0.0011550472,0.0024361531,0.004285094],"category_scores_gemma":[0.0036742124,0.000852901,0.0028695113,0.0006160658,0.0015678977,0.0012059325,0.0005496649,0.0022129768,0.00053444295],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9892134,0.0048470087,0.00043724958,0.0003891564,0.00069350784,0.000013316289,0.00001661163,0.000058702528,0.0009432835,0.000020539192,0.00008725048,0.0032799162],"study_design_scores_gemma":[0.88771003,0.109562516,0.0012164409,0.0000306988,0.0007953465,0.000015029128,0.000011423487,0.00020912384,0.0002658718,0.00003382489,0.000139202,0.0000105516765],"about_ca_topic_score_codex":0.00047497786,"about_ca_topic_score_gemma":0.0009229577,"teacher_disagreement_score":0.004321642,"about_ca_system_score_codex":0.0007697337,"about_ca_system_score_gemma":0.0012537158,"threshold_uncertainty_score":0.020754993},"labels":[],"label_agreement":null},{"id":"W4407613426","doi":"10.1177/17562848251314827","title":"Exploring the connection between erythrocyte membrane fatty acid composition and oxidative stress in patients undergoing the Crohn’s disease Therapeutic Diet Intervention (CD-TDI)","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Medicine; Oxidative stress; Polyunsaturated fatty acid; Crohn's disease; Internal medicine; Malondialdehyde; Inflammatory bowel disease; Fatty acid; Endocrinology; Disease; Biochemistry; Chemistry","score_opus":0.037164963011115826,"score_gpt":0.3225490004525236,"score_spread":0.2853840374414078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407613426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939585,0.00038137162,0.0000568721,0.000021545451,0.000003448058,0.00002489902,0.00003271429,9.0069335e-7,0.00008234739],"genre_scores_gemma":[0.9993649,0.00014612234,0.00025140945,0.00003075574,0.000006900879,0.000043765187,0.00008079606,3.5807622e-7,0.000074909076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965215,0.00016774372,0.000037828046,0.000060279566,0.000038368973,0.00004373274],"domain_scores_gemma":[0.9992405,0.00020430588,0.00029181186,0.0000381625,0.00008652918,0.00013867258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095636444,0.0002247067,0.00063036935,0.00030299075,0.00030077746,0.00028844472,0.00016520858,0.00047475807,0.0009627004],"category_scores_gemma":[0.0013953567,0.00019308554,0.000384751,0.00036974857,0.00018452769,0.00022937283,0.00023224752,0.0004306823,0.000102487604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030855637,0.003034675,0.93539196,0.00030636814,0.0004616558,0.000114927294,0.000300492,0.000120836354,0.0067437035,0.000029706836,0.0001285113,0.022511486],"study_design_scores_gemma":[0.0010743713,0.023411198,0.9732309,0.000026954443,0.00033921874,0.00019531601,0.00017623871,0.00024992356,0.00090604974,0.00003341237,0.00034823027,0.000008086657],"about_ca_topic_score_codex":0.0003874717,"about_ca_topic_score_gemma":0.00064630894,"teacher_disagreement_score":0.0009627004,"about_ca_system_score_codex":0.0002081461,"about_ca_system_score_gemma":0.00024250968,"threshold_uncertainty_score":0.0050578117},"labels":[],"label_agreement":null},{"id":"W4407667477","doi":"10.1177/17562848251319807","title":"“Simpleness”: a qualitative description study exploring patient perspectives on the barriers and facilitators of using digital health tools to self-manage inflammatory bowel disease","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"Alberta Innovates - Health Solutions","keywords":"Thematic analysis; Medicine; Usability; Digital health; Qualitative research; Health care; Credibility; Disease management; Patient portal; Self-management; Nursing; Knowledge management; Medical education; Health management system; Alternative medicine; Computer science","score_opus":0.02399174349080221,"score_gpt":0.3125680524862257,"score_spread":0.2885763089954235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407667477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583045,0.0016160503,0.011614797,0.013958254,0.0002852713,0.0013390885,0.00069484644,0.00008081746,0.012106341],"genre_scores_gemma":[0.982473,0.0011798306,0.004640652,0.004551119,0.00005281203,0.0015790574,0.00023504192,0.00006771622,0.005220771],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9805817,0.015586788,0.00048036085,0.00077404815,0.00088838034,0.0016887549],"domain_scores_gemma":[0.96507484,0.026832769,0.0015331027,0.00079261075,0.0028369492,0.0029297348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021527393,0.0009001807,0.0010086236,0.0014693442,0.010764868,0.0047251116,0.0026177631,0.0025166315,0.0050932947],"category_scores_gemma":[0.026991438,0.00070694304,0.0007709354,0.0015665076,0.009750583,0.005383549,0.0059748534,0.0038608687,0.00062520965],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041641564,0.000037900834,0.0010034699,0.0002269931,0.000003834608,0.00059900724,0.9925168,0.00003259808,0.0005816631,0.00089553476,0.0007445753,0.003316041],"study_design_scores_gemma":[0.000007978318,0.000064083775,0.00051933975,0.0002315236,0.0000041643775,0.00024935004,0.98752147,0.00008115246,0.00024770942,0.00033368266,0.010723589,0.000015965654],"about_ca_topic_score_codex":0.011399097,"about_ca_topic_score_gemma":0.0164216,"teacher_disagreement_score":0.021527393,"about_ca_system_score_codex":0.009642017,"about_ca_system_score_gemma":0.009762736,"threshold_uncertainty_score":0.1138491},"labels":[],"label_agreement":null},{"id":"W4407895536","doi":"10.1177/17562848251321915","title":"Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Lawson Health Research Institute; Western University","funders":"","keywords":"Clinical trial; Medicine; Data sharing; Transformative learning; Precision medicine; Big data; Artificial intelligence; Data science; Alternative medicine; Computer science; Psychology; Data mining; Pathology","score_opus":0.5441135652873395,"score_gpt":0.6230514199549625,"score_spread":0.07893785466762304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407895536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004919549,0.9981294,0.00024303918,0.00082530815,0.00016429585,0.000014075267,0.0000116397205,0.0000094395,0.0005536581],"genre_scores_gemma":[0.00048525972,0.99810237,0.0004754174,0.0006265475,0.0001712069,0.000019072308,0.000019646375,0.0000032137411,0.00009733052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833375,0.0006006267,0.000321925,0.00017319433,0.000482801,0.00008768452],"domain_scores_gemma":[0.9898173,0.008153506,0.0006301722,0.00015721376,0.000987009,0.00025465412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004949033,0.0012046862,0.0018455714,0.0048648654,0.00053627405,0.0026919998,0.0016460841,0.0029698506,0.003557259],"category_scores_gemma":[0.009028395,0.0006158319,0.0020097932,0.00455375,0.0012361618,0.0030166914,0.0018005987,0.003596597,0.0011760416],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008092141,0.00007823227,0.000242394,0.04828203,0.00031083365,0.00010246766,0.00013988208,0.0008047025,0.00035278208,0.008499668,0.02722794,0.9138782],"study_design_scores_gemma":[0.00005098982,0.00017991861,0.0011243004,0.06945363,0.0007498511,0.00059741025,0.00013647549,0.00049794087,0.00032547777,0.010284072,0.91653645,0.00006344352],"about_ca_topic_score_codex":0.002064915,"about_ca_topic_score_gemma":0.0031353424,"teacher_disagreement_score":0.004949033,"about_ca_system_score_codex":0.0017385556,"about_ca_system_score_gemma":0.004324292,"threshold_uncertainty_score":0.026173294},"labels":[],"label_agreement":null},{"id":"W4407985628","doi":"10.1177/17562848251323004","title":"Tryptophan metabolites profile predict remission with dietary therapy in pediatric Crohn’s disease","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Université François-Rabelais; Amsterdam University Medical Centers; European Crohn's and Colitis Organisation; Mount Saint Vincent University; Pfizer","keywords":"Medicine; Gastroenterology; Internal medicine; Randomized controlled trial; Tryptophan; Feces; Crohn's disease; Receiver operating characteristic; Area under the curve; Inflammatory bowel disease; Disease; Biology; Biochemistry","score_opus":0.005902273541860662,"score_gpt":0.25664693084760515,"score_spread":0.25074465730574447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407985628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976954,0.0016397455,0.00025856833,0.000027390264,0.0000035363842,0.000023042976,0.00018789424,0.000004000513,0.00016035605],"genre_scores_gemma":[0.9989054,0.0002445266,0.00057022227,0.000015950383,0.000004313059,0.000020802687,0.00020514586,0.000001273652,0.0000323501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926215,0.00032504043,0.00011562858,0.00012140662,0.00013007279,0.00004565749],"domain_scores_gemma":[0.9973916,0.001079247,0.001110752,0.00008527138,0.00019801965,0.00013513828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015374683,0.00029049272,0.0005149323,0.0005070391,0.00013529276,0.0003502365,0.00014014069,0.00030195547,0.00058303226],"category_scores_gemma":[0.0035680584,0.00014499782,0.00045685886,0.00044254653,0.00018422144,0.0002716916,0.00022284346,0.00032494226,0.00008617132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028556946,0.00012905258,0.9845296,0.00010073262,0.00015680981,0.000060542985,0.000033306947,0.00020512115,0.001228312,0.000010768171,0.000045495945,0.010644423],"study_design_scores_gemma":[0.00014127306,0.00214485,0.9942173,0.000035064775,0.0002699937,0.00045728794,0.00004469533,0.0010773984,0.0013177048,0.00003445172,0.00025486737,0.000005166198],"about_ca_topic_score_codex":0.00036689424,"about_ca_topic_score_gemma":0.0006175669,"teacher_disagreement_score":0.0015374683,"about_ca_system_score_codex":0.00022061962,"about_ca_system_score_gemma":0.00025434257,"threshold_uncertainty_score":0.008131027},"labels":[],"label_agreement":null},{"id":"W4410589534","doi":"10.1177/17562848251335824","title":"MASLD and liver fibrosis in patients with psoriasis receiving IL-17 or IL-23 inhibitors: a systematic review","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Medicine; Internal medicine; Randomized controlled trial; Psoriasis; Cohort study; Systematic review; Cohort; Observational study; Clinical trial; Relative risk; MEDLINE; Immunology; Confidence interval","score_opus":0.014594544777399226,"score_gpt":0.26961400377438827,"score_spread":0.255019458996989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410589534","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015496145,0.9975763,0.0000825943,0.00013541723,0.000053817297,0.00022141926,0.00023531078,0.0000059366175,0.00013955777],"genre_scores_gemma":[0.030513372,0.96734995,0.0005322718,0.00051815377,0.00010771352,0.000600646,0.00025600518,0.00000518801,0.00011672694],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99496573,0.0017219284,0.00184734,0.00046897365,0.00082631636,0.00016969087],"domain_scores_gemma":[0.9824944,0.012041113,0.0037932498,0.00022938922,0.001214225,0.00022766402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052925455,0.0013809673,0.010149743,0.006987998,0.00058487453,0.0021519198,0.0015594384,0.0019303197,0.0042608012],"category_scores_gemma":[0.022239624,0.0010071497,0.010455584,0.0072352462,0.0007038024,0.0017302502,0.0011870329,0.0010668545,0.00023144222],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037993214,0.000018401664,0.0012758184,0.9586881,0.021409512,0.000083805295,0.0000888551,0.0000798209,0.000102937964,0.00009089971,0.00074004236,0.017041901],"study_design_scores_gemma":[0.0008344887,0.00041179892,0.01063075,0.6755229,0.3008955,0.00066141976,0.00023536063,0.00019460967,0.00018812506,0.0003318506,0.01003329,0.000059811257],"about_ca_topic_score_codex":0.006600284,"about_ca_topic_score_gemma":0.017869916,"teacher_disagreement_score":0.010149743,"about_ca_system_score_codex":0.002398664,"about_ca_system_score_gemma":0.0064807096,"threshold_uncertainty_score":0.027989984},"labels":[],"label_agreement":null},{"id":"W4411023152","doi":"10.1177/17562848251339878","title":"Progressing or preserving, disease extent evolution in hospitalized patients with ulcerative colitis in China: a real-world study","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ulcerative colitis; Internal medicine; Disease; Proportional hazards model; Retrospective cohort study; Cohort; Logistic regression; Proctitis; Gastroenterology","score_opus":0.004912037482061353,"score_gpt":0.2800623872286377,"score_spread":0.2751503497465763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411023152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99959165,0.00012440211,0.000015316165,0.000026312166,0.0000015324239,0.0000073250367,0.00015101701,7.9606565e-7,0.00008165931],"genre_scores_gemma":[0.9994777,0.00012947663,0.00003051867,0.000022651666,0.0000065145036,0.000008017325,0.00028651804,6.041775e-7,0.00003799367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995701,0.00007924763,0.000068237714,0.000105994695,0.00006246784,0.0001140153],"domain_scores_gemma":[0.99861133,0.00012524791,0.0006637498,0.0000919811,0.00013610232,0.00037157827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065433455,0.00032188548,0.00033716296,0.00089771143,0.0007948277,0.0006701324,0.0003815848,0.00044859518,0.0006904737],"category_scores_gemma":[0.001574299,0.00031982592,0.00048595932,0.0014316508,0.0005196116,0.00078065344,0.00062141236,0.00044842716,0.00009420481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034876808,0.00001039873,0.9994696,0.000007128591,0.0000105444105,0.00006747101,0.000084011794,0.000011328545,0.00003125815,0.000005511859,0.000021898926,0.00024588947],"study_design_scores_gemma":[0.0000039062643,0.000046937734,0.9993875,0.0000042488323,0.00001178526,0.00012037439,0.00027225298,0.00007539183,0.000009427587,0.0000073858596,0.00005831026,0.000002504037],"about_ca_topic_score_codex":0.028258882,"about_ca_topic_score_gemma":0.028218182,"teacher_disagreement_score":0.028258882,"about_ca_system_score_codex":0.0010968738,"about_ca_system_score_gemma":0.001233916,"threshold_uncertainty_score":0.05618882},"labels":[],"label_agreement":null},{"id":"W4411244591","doi":"10.1177/17562848251342340","title":"Role of medico-administrative database in the selection of the target population in colorectal cancer screening program","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Family medicine; Colorectal cancer; Colonoscopy; Descriptive statistics; MEDLINE; Cancer; Environmental health; Internal medicine; Statistics","score_opus":0.01667958311375903,"score_gpt":0.3483663490319294,"score_spread":0.33168676591817037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411244591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85468274,0.072162956,0.012179453,0.010223097,0.00035884322,0.002196093,0.028679568,0.00013313495,0.019384133],"genre_scores_gemma":[0.98161733,0.005845553,0.00548617,0.00075502053,0.00008025827,0.00082593865,0.0051939883,0.000016788574,0.00017903952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.923325,0.04944815,0.013836909,0.0034315349,0.008715891,0.0012425475],"domain_scores_gemma":[0.7481186,0.17735799,0.0453271,0.00705594,0.018782942,0.0033574644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05162146,0.00023767789,0.0011763939,0.007100522,0.0007704168,0.003402936,0.0016975922,0.0006193669,0.0015770264],"category_scores_gemma":[0.15249713,0.00031791892,0.0008032285,0.013836627,0.00042419418,0.0023826396,0.0021014821,0.0005135427,0.00029249478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046802708,0.00015445851,0.93746316,0.004202163,0.0005231003,0.00009967904,0.0010393066,0.0003039652,0.0001105048,0.0008356481,0.0018300076,0.052969936],"study_design_scores_gemma":[0.00012114277,0.00033058872,0.96807736,0.006628506,0.0012737234,0.0004584123,0.0045319935,0.0031654544,0.0007037886,0.0009786851,0.013673642,0.000056717217],"about_ca_topic_score_codex":0.00743658,"about_ca_topic_score_gemma":0.0065840464,"teacher_disagreement_score":0.05162146,"about_ca_system_score_codex":0.0018497321,"about_ca_system_score_gemma":0.0056452593,"threshold_uncertainty_score":0.27300358},"labels":[],"label_agreement":null},{"id":"W4413307108","doi":"10.1177/17562848251363703","title":"Asia Pacific association of gastroenterology consensus statements on histopathological evaluation of inflammatory bowel diseases","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Gastroenterology; Internal medicine; Inflammatory Bowel Diseases; Ulcerative colitis; Asia pacific; Association (psychology); Pathology; General surgery; Disease","score_opus":0.010591064293821666,"score_gpt":0.3067016564120919,"score_spread":0.29611059211827023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413307108","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012682132,0.1672513,0.08507661,0.53432494,0.05841837,0.023311747,0.005284746,0.0006937402,0.112956434],"genre_scores_gemma":[0.15432096,0.2397723,0.37523848,0.11291351,0.012053777,0.059585724,0.013358852,0.0005625518,0.032193802],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7761956,0.1262297,0.05091428,0.004551889,0.037505668,0.0046028583],"domain_scores_gemma":[0.6242028,0.09115216,0.03816541,0.00937538,0.22277732,0.014326879],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.19722912,0.0021645885,0.0026454043,0.010629107,0.004190997,0.0065046884,0.007589784,0.011340833,0.0055770185],"category_scores_gemma":[0.26425222,0.0016811825,0.0040206676,0.0091395965,0.0052485866,0.0054267785,0.011650051,0.012516056,0.0040424233],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004874273,0.00026509116,0.005963863,0.0533281,0.0006355087,0.0014253602,0.014611257,0.0018935818,0.002428404,0.023411812,0.5435331,0.35201648],"study_design_scores_gemma":[0.00030281325,0.00029991893,0.010625869,0.080683924,0.0005148868,0.0019405681,0.0074280687,0.0009964668,0.0010473531,0.023893313,0.8720195,0.00024736038],"about_ca_topic_score_codex":0.009299187,"about_ca_topic_score_gemma":0.006470303,"teacher_disagreement_score":0.19722912,"about_ca_system_score_codex":0.008930971,"about_ca_system_score_gemma":0.08033344,"threshold_uncertainty_score":0.9899594},"labels":[],"label_agreement":null},{"id":"W4414828950","doi":"10.1177/17562848251358168","title":"Adalimumab around the world: comparative analysis of products characteristics and patient support systems","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Adalimumab; Usability; Biosimilar; Dosing; MEDLINE; Patient safety; Patient satisfaction; Psychological intervention","score_opus":0.04039737541785968,"score_gpt":0.36537673269169263,"score_spread":0.324979357273833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414828950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032324243,0.96319735,0.0002845779,0.00052155775,0.00008750794,0.00012222756,0.0011468654,0.000012748071,0.0023030012],"genre_scores_gemma":[0.18826406,0.8053327,0.002052799,0.001091269,0.00018594123,0.00025415374,0.0022939187,0.000031129333,0.00049402984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955106,0.0012018544,0.0014295001,0.0005135537,0.0012113281,0.00013320892],"domain_scores_gemma":[0.9871141,0.0078165,0.0029220523,0.00018309076,0.001769926,0.00019428927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004302966,0.0004140137,0.0017246791,0.004256539,0.00024357402,0.0019475986,0.00037874837,0.00061895524,0.0022437773],"category_scores_gemma":[0.012036405,0.00020034444,0.0025026537,0.0064541143,0.00035176342,0.0015661251,0.00048473288,0.0006802149,0.00030195146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005780103,0.0002071928,0.026225714,0.11531052,0.009036197,0.00034171282,0.0010800678,0.00032994017,0.0020167,0.0011552443,0.006892215,0.83162445],"study_design_scores_gemma":[0.0020531954,0.012151851,0.39386046,0.10307773,0.058302265,0.008859895,0.0051615136,0.000975745,0.0051285434,0.0022337614,0.40780407,0.00039096258],"about_ca_topic_score_codex":0.0016205282,"about_ca_topic_score_gemma":0.0026953737,"teacher_disagreement_score":0.004302966,"about_ca_system_score_codex":0.00088449044,"about_ca_system_score_gemma":0.0016921262,"threshold_uncertainty_score":0.022756517},"labels":[],"label_agreement":null},{"id":"W4414947707","doi":"10.1177/17562848251383767","title":"Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Cilag; Samsung; Celgene; Biogen; Gilead Sciences; United European Gastroenterology; Celltrion; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vedolizumab; Systematic review; Discontinuation; Infliximab; Inflammatory bowel disease; Ulcerative colitis; Ustekinumab; MEDLINE; Biosimilar","score_opus":0.011456790443229283,"score_gpt":0.28816413606560837,"score_spread":0.2767073456223791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414947707","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011771538,0.9864785,0.0005353912,0.00013432362,0.00010333974,0.00027241537,0.00051246834,0.00001791952,0.00017396516],"genre_scores_gemma":[0.3426412,0.6504616,0.00252353,0.00074284826,0.00027149852,0.0018483056,0.0012248332,0.000033178847,0.00025298216],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97338253,0.011878066,0.008982352,0.0024685427,0.0028356288,0.00045288893],"domain_scores_gemma":[0.9423758,0.039731145,0.013270755,0.0014472948,0.0027363927,0.00043865264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03089051,0.0022229734,0.019170497,0.009667513,0.0005618385,0.0030713126,0.0023893134,0.002325355,0.0017645118],"category_scores_gemma":[0.05627541,0.0018144033,0.05807452,0.008376365,0.0007869712,0.0016209971,0.0015565812,0.0017615847,0.00017502782],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023412902,0.000026763963,0.010377634,0.1914363,0.78599936,0.00010901128,0.00009063946,0.00039037532,0.000099972494,0.00005870323,0.00025565876,0.008814261],"study_design_scores_gemma":[0.00058922375,0.0002634066,0.007924522,0.016471794,0.97348726,0.00017709077,0.000045236826,0.00018873248,0.000084373634,0.000092696624,0.0006491551,0.000026463698],"about_ca_topic_score_codex":0.004721335,"about_ca_topic_score_gemma":0.008005576,"teacher_disagreement_score":0.03089051,"about_ca_system_score_codex":0.003257618,"about_ca_system_score_gemma":0.00320259,"threshold_uncertainty_score":0.16336656},"labels":[],"label_agreement":null},{"id":"W4415458995","doi":"10.1177/17562848251387501","title":"Dynamic changes in serum alpha-fetoprotein predict prognosis in hepatocellular carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepatocellular carcinoma; Immune checkpoint; Immune system; Nivolumab; Immunotherapy; Carcinoma","score_opus":0.042061272043501345,"score_gpt":0.29844791246290625,"score_spread":0.2563866404194049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415458995","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003273286,0.99569315,0.00022777426,0.000133219,0.000068778034,0.00012891518,0.000329306,0.000011269683,0.00013436556],"genre_scores_gemma":[0.10347561,0.8930606,0.0011266965,0.0006118383,0.00018974149,0.0006361672,0.0006907627,0.000016802847,0.00019165908],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944047,0.0023939633,0.0017316857,0.0006237176,0.00063794677,0.00020795097],"domain_scores_gemma":[0.9821525,0.013655342,0.0025082962,0.00040855358,0.0010937079,0.00018167584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009136747,0.0022556698,0.015881399,0.005680671,0.0005654417,0.0028042544,0.0019740795,0.001882995,0.0024439842],"category_scores_gemma":[0.026806233,0.0011667613,0.029770251,0.007255283,0.00056913815,0.0013536215,0.0011931862,0.0015262491,0.00023114143],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013286122,0.00002938418,0.006362874,0.50333,0.47154593,0.00014706867,0.0000934697,0.0005647342,0.00023408566,0.00011014409,0.0006036348,0.015650084],"study_design_scores_gemma":[0.000255393,0.0001679004,0.004963548,0.034232218,0.95835084,0.000110406305,0.00004397971,0.00016781637,0.000093805575,0.00013050932,0.001461336,0.000022195649],"about_ca_topic_score_codex":0.0065176683,"about_ca_topic_score_gemma":0.014524668,"teacher_disagreement_score":0.015881399,"about_ca_system_score_codex":0.0020667897,"about_ca_system_score_gemma":0.0037146292,"threshold_uncertainty_score":0.048320353},"labels":[],"label_agreement":null},{"id":"W4416144529","doi":"10.1177/17562848251395566","title":"Integrated analysis of the safety of fecal microbiota, live-jslm in adults with recurrent <i>Clostridioides difficile</i> infection from five prospective clinical trials: an update","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Victoria; University of British Columbia","funders":"","keywords":"Feces; Prospective cohort study; Incidence (geometry); Clinical trial; Fecal bacteriotherapy","score_opus":0.0268993107662846,"score_gpt":0.37459244775640627,"score_spread":0.34769313699012167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416144529","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20366089,0.76863563,0.005538067,0.003055921,0.0005957842,0.0030443587,0.0087018395,0.0002569964,0.0065104966],"genre_scores_gemma":[0.74070287,0.21856019,0.014981657,0.0047679595,0.0010990434,0.0032054388,0.015184022,0.000113614005,0.0013852667],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9878736,0.0056792838,0.0031827528,0.0008604162,0.0020995203,0.00030435433],"domain_scores_gemma":[0.95972127,0.014711759,0.016387038,0.0021596884,0.0061464747,0.0008737106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027978133,0.0007093867,0.0030544724,0.0018865033,0.00032493455,0.0027137592,0.0009544025,0.0011010639,0.002294842],"category_scores_gemma":[0.025277013,0.0004892395,0.003702056,0.0025756424,0.0005036607,0.0015997773,0.0008600582,0.0011507302,0.0003373927],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053961217,0.0009933644,0.08110777,0.07558026,0.058879558,0.00023864949,0.00040465576,0.001379809,0.010962628,0.0006726085,0.010358713,0.7054608],"study_design_scores_gemma":[0.045871124,0.07510724,0.42810974,0.04805227,0.21826482,0.0030526298,0.0005879478,0.002518876,0.012526068,0.0020325913,0.16352794,0.00034880632],"about_ca_topic_score_codex":0.0006915382,"about_ca_topic_score_gemma":0.002938603,"teacher_disagreement_score":0.027978133,"about_ca_system_score_codex":0.0011135527,"about_ca_system_score_gemma":0.002645568,"threshold_uncertainty_score":0.1479643},"labels":[],"label_agreement":null},{"id":"W65908905","doi":"10.1177/1756283x10373176","title":"Review: Anti-adhesion molecule therapy for inflammatory bowel disease","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Natalizumab; Inflammatory bowel disease; Inflammation; Vedolizumab; Tumor necrosis factor alpha; Immunology; Cell adhesion molecule; Crohn's disease; Disease; Integrin; Monoclonal antibody; Cancer research; Antibody; Internal medicine; Receptor","score_opus":0.00674600686005434,"score_gpt":0.2736574793723124,"score_spread":0.26691147251225805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W65908905","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007647738,0.99412185,0.00010049636,0.0008723997,0.00336908,0.000014859703,0.000036957998,0.000013832523,0.0013941533],"genre_scores_gemma":[0.0005055826,0.9937714,0.00016383984,0.0013628994,0.002490386,0.00001923906,0.0000732814,0.0000039725983,0.0016095164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961543,0.00007806199,0.00006974074,0.000056103927,0.00015068555,0.00002988656],"domain_scores_gemma":[0.9993175,0.00028044244,0.00011707719,0.000015828966,0.0001907426,0.000078394994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053701195,0.0010262962,0.0014174094,0.00185728,0.00034194757,0.0014366795,0.0011219911,0.001927262,0.0072811525],"category_scores_gemma":[0.0012499165,0.00021065355,0.0006082281,0.0019686383,0.00042414808,0.0014563896,0.0005618875,0.0026149587,0.0053238077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013169569,0.00008474327,0.000102825696,0.020507459,0.000111426714,0.00019251122,0.000037800957,0.00023350018,0.0011073238,0.0015390422,0.26205155,0.7139],"study_design_scores_gemma":[0.000028538456,0.000089138855,0.0004570715,0.0033545552,0.00008737757,0.0007104204,0.000024468643,0.00004166959,0.00013582126,0.00053486245,0.99452597,0.000010245548],"about_ca_topic_score_codex":0.00063855236,"about_ca_topic_score_gemma":0.0012843527,"teacher_disagreement_score":0.0072811525,"about_ca_system_score_codex":0.0006494871,"about_ca_system_score_gemma":0.00087611825,"threshold_uncertainty_score":0.024357915},"labels":[],"label_agreement":null},{"id":"W7116968462","doi":"10.1177/17562848251403009","title":"Effectiveness of ustekinumab in Crohn’s disease across intestinal locations: spotlight on isolated small intestinal involvement","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Department of Education of Zhejiang Province","keywords":"Ustekinumab; Disease; Crohn's disease; Inflammatory bowel disease; Intestinal mucosa","score_opus":0.008374039543015771,"score_gpt":0.2842808799602634,"score_spread":0.27590684041724767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116968462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66495335,0.32904518,0.00036703455,0.0021164126,0.00019470781,0.000047290858,0.00022881314,0.000015808731,0.0030314059],"genre_scores_gemma":[0.97093755,0.02729456,0.00027385596,0.00055608456,0.0006189307,0.000018106235,0.00014355328,0.000006223698,0.00015131709],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981021,0.00090708025,0.00024919433,0.00022273374,0.00033870494,0.00018022965],"domain_scores_gemma":[0.9910574,0.0048773307,0.0024894238,0.00032854805,0.00063620764,0.0006111276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004644043,0.00027027808,0.00149717,0.0005372948,0.00017082912,0.0007528426,0.00031207118,0.00044273687,0.001621929],"category_scores_gemma":[0.0056178705,0.00010119331,0.0009766216,0.00064260646,0.00056185934,0.0010310379,0.00043058666,0.0007169002,0.00017401723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025735568,0.0006688622,0.2365911,0.0032299017,0.002347108,0.00021217825,0.0002603642,0.0006863321,0.0036564781,0.0003802228,0.0017611211,0.72447073],"study_design_scores_gemma":[0.002583249,0.036148466,0.93102276,0.0029188031,0.0056997277,0.0020933852,0.0006859341,0.0014879749,0.0027242596,0.0011775723,0.013404929,0.00005299553],"about_ca_topic_score_codex":0.00026060976,"about_ca_topic_score_gemma":0.00074347894,"teacher_disagreement_score":0.004644043,"about_ca_system_score_codex":0.00036960127,"about_ca_system_score_gemma":0.00027318642,"threshold_uncertainty_score":0.024560332},"labels":[],"label_agreement":null}]}